organization · Reporting owner

VHCP Management EG, LLC

Disclosed activity across 4 companies

Tapewire entity: 55707
SEC CIK: 0001808518

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
Oruka Therapeutics, Inc.ORKA · Entity 3781	10% owner	February 10, 2025	February 27, 2025

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Oruka Therapeutics, Inc.

Report date February 10, 2025 · Filed February 27, 2025

Jointly reported with Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management III, LLC, Koh Bong Y, Shah Nimish P

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	IndirectBy Funds	4,026,120	Reported balance After 2025-02-10 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 1 · 2025-02-10 · Purchase · Acquired 574 · Balance 4,026,120 F1: The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $10.88 to $11.00 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote. F2: Consists of (i) 835,614 shares held by VHCP3; (ii) 83,701 shares held by VHCP Co-3; and (iii) 3,106,805 shares held by VHCP EG. F3: VHCP Management III, LLC ("VHCPM3") is the general partner of VHCP3 and the manager of VHCP Co-3 and may be deemed to beneficially own these securities. VHCP Management EG, LLC ("VHCPMEG") is the general partner of VHCPEG and may be deemed to beneficially own these securities. Bong Koh and Nimish Shah are the voting members of VHCPM3 and VHCPMEG and may be deemed to beneficially own these securities. Each of VHCPM3, VHCPMEG and Messrs. Koh and Shah expressly disclaims beneficial ownership over these securities except to the extent of its or his indirect pecuniary interest therein.
Common StockSEC Table I · non-derivative	IndirectBy Funds	4,035,713	Reported balance After 2025-02-11 transaction · row 2 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 2 · 2025-02-11 · Purchase · Acquired 9,593 · Balance 4,035,713 F4: The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $10.86 to $11.00 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote. F5: Consists of (i) 837,271 shares held by VHCP3; (ii) 83,867 shares held by VHCP Co-3; and (iii) 3,114,575 shares held by VHCP EG. F3: VHCP Management III, LLC ("VHCPM3") is the general partner of VHCP3 and the manager of VHCP Co-3 and may be deemed to beneficially own these securities. VHCP Management EG, LLC ("VHCPMEG") is the general partner of VHCPEG and may be deemed to beneficially own these securities. Bong Koh and Nimish Shah are the voting members of VHCPM3 and VHCPMEG and may be deemed to beneficially own these securities. Each of VHCPM3, VHCPMEG and Messrs. Koh and Shah expressly disclaims beneficial ownership over these securities except to the extent of its or his indirect pecuniary interest therein.
Common StockSEC Table I · non-derivative	IndirectBy Funds	4,044,684	Reported balance After 2025-02-12 transaction · row 3 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 3 · 2025-02-12 · Purchase · Acquired 8,971 · Balance 4,044,684 F6: The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $11.25 to $12.00 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote. F7: Consists of (i) 838,821 shares held by VHCP3; (ii) 84,022 shares held by VHCP Co-3; and (iii) 3,121,841 shares held by VHCP EG. F3: VHCP Management III, LLC ("VHCPM3") is the general partner of VHCP3 and the manager of VHCP Co-3 and may be deemed to beneficially own these securities. VHCP Management EG, LLC ("VHCPMEG") is the general partner of VHCPEG and may be deemed to beneficially own these securities. Bong Koh and Nimish Shah are the voting members of VHCPM3 and VHCPMEG and may be deemed to beneficially own these securities. Each of VHCPM3, VHCPMEG and Messrs. Koh and Shah expressly disclaims beneficial ownership over these securities except to the extent of its or his indirect pecuniary interest therein.
Common StockSEC Table I · non-derivative	IndirectBy Funds	4,059,634	Reported balance After 2025-02-13 transaction · row 4 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 4 · 2025-02-13 · Purchase · Acquired 14,950 · Balance 4,059,634 F8: The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $11.31 to $11.74 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote. F9: Consists of (i) 841,404 shares held by VHCP3; (ii) 84,280 shares held by VHCP Co-3; and (iii) 3,133,950 shares held by VHCP EG. F3: VHCP Management III, LLC ("VHCPM3") is the general partner of VHCP3 and the manager of VHCP Co-3 and may be deemed to beneficially own these securities. VHCP Management EG, LLC ("VHCPMEG") is the general partner of VHCPEG and may be deemed to beneficially own these securities. Bong Koh and Nimish Shah are the voting members of VHCPM3 and VHCPMEG and may be deemed to beneficially own these securities. Each of VHCPM3, VHCPMEG and Messrs. Koh and Shah expressly disclaims beneficial ownership over these securities except to the extent of its or his indirect pecuniary interest therein.
Common StockSEC Table I · non-derivative	IndirectBy Funds	4,148,428	Reported balance After 2025-02-14 transaction · row 5 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 5 · 2025-02-14 · Purchase · Acquired 88,794 · Balance 4,148,428 F10: The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $11.17 to $11.45 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote. F11: Consists of (i) 856,747 shares held by VHCP3; (ii) 85,816 shares held by VHCP Co-3; and (iii) 3,205,865 shares held by VHCP EG. F3: VHCP Management III, LLC ("VHCPM3") is the general partner of VHCP3 and the manager of VHCP Co-3 and may be deemed to beneficially own these securities. VHCP Management EG, LLC ("VHCPMEG") is the general partner of VHCPEG and may be deemed to beneficially own these securities. Bong Koh and Nimish Shah are the voting members of VHCPM3 and VHCPMEG and may be deemed to beneficially own these securities. Each of VHCPM3, VHCPMEG and Messrs. Koh and Shah expressly disclaims beneficial ownership over these securities except to the extent of its or his indirect pecuniary interest therein.

Filing footnotes · ownership attribution and instrument terms

F1: The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $10.88 to $11.00 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote.

F2: Consists of (i) 835,614 shares held by VHCP3; (ii) 83,701 shares held by VHCP Co-3; and (iii) 3,106,805 shares held by VHCP EG.

F3: VHCP Management III, LLC ("VHCPM3") is the general partner of VHCP3 and the manager of VHCP Co-3 and may be deemed to beneficially own these securities. VHCP Management EG, LLC ("VHCPMEG") is the general partner of VHCPEG and may be deemed to beneficially own these securities. Bong Koh and Nimish Shah are the voting members of VHCPM3 and VHCPMEG and may be deemed to beneficially own these securities. Each of VHCPM3, VHCPMEG and Messrs. Koh and Shah expressly disclaims beneficial ownership over these securities except to the extent of its or his indirect pecuniary interest therein.

F4: The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $10.86 to $11.00 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote.

F5: Consists of (i) 837,271 shares held by VHCP3; (ii) 83,867 shares held by VHCP Co-3; and (iii) 3,114,575 shares held by VHCP EG.

F6: The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $11.25 to $12.00 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote.

F7: Consists of (i) 838,821 shares held by VHCP3; (ii) 84,022 shares held by VHCP Co-3; and (iii) 3,121,841 shares held by VHCP EG.

F8: The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $11.31 to $11.74 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote.

F9: Consists of (i) 841,404 shares held by VHCP3; (ii) 84,280 shares held by VHCP Co-3; and (iii) 3,133,950 shares held by VHCP EG.

F10: The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $11.17 to $11.45 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote.

F11: Consists of (i) 856,747 shares held by VHCP3; (ii) 85,816 shares held by VHCP Co-3; and (iii) 3,205,865 shares held by VHCP EG.

Past disclosures · reporting ended (3)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

KalVista Pharmaceuticals, Inc.

Report date March 25, 2026 · Filed March 27, 2026

Section 16 reporting ended · disclosed 2026-03-27. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	IndirectBy Funds	5,129,500	Reported balance After 2026-03-25 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 1 · 2026-03-25 · Sale · Disposed 174,485 · Balance 5,129,500 F1: The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $16.51 to $17.50 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote. F2: Consists of (i) 1,105,126 shares held by Venrock Healthcare Capital Partners III, L.P. ("VHCP3"); (ii) 110,550 shares held by VHCP Co-Investment Holdings III,LLC ("VHCP Co-3"); and (iii) 3,913,824 shares held by Venrock Healthcare Capital Partners EG, L.P. ("VHCP EG"). F3: VHCP Management III, LLC ("VHCPM3") is the general partner of VHCP3 and the manager of VHCP Co-3 and may be deemed to beneficially own these securities. VHCP Management EG, LLC ("VHCPMEG") is the general partner of VHCPEG and may be deemed to beneficially own these securities. Bong Koh and Nimish Shah are the voting members of VHCPM3 and VHCPMEG and may be deemed to beneficially own these securities. Each of VHCPM3, VHCPMEG and Messrs. Koh and Shah expressly disclaims beneficial ownership over these securities except to the extent of its or his indirect pecuniary interest therein.
Common StockSEC Table I · non-derivative	IndirectBy Funds	5,129,340	Reported balance After 2026-03-25 transaction · row 2 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 2 · 2026-03-25 · Sale · Disposed 160 · Balance 5,129,340 F4: The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $17.51 to $17.55 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote. F5: Consists of (i) 1,105,092 shares held by VHCP3; (ii) 110,547 shares held by VHCP Co-3; and (iii) 3,913,701 shares held by VHCP EG. F3: VHCP Management III, LLC ("VHCPM3") is the general partner of VHCP3 and the manager of VHCP Co-3 and may be deemed to beneficially own these securities. VHCP Management EG, LLC ("VHCPMEG") is the general partner of VHCPEG and may be deemed to beneficially own these securities. Bong Koh and Nimish Shah are the voting members of VHCPM3 and VHCPMEG and may be deemed to beneficially own these securities. Each of VHCPM3, VHCPMEG and Messrs. Koh and Shah expressly disclaims beneficial ownership over these securities except to the extent of its or his indirect pecuniary interest therein.
Common StockSEC Table I · non-derivative	IndirectBy Funds	5,107,954	Reported balance After 2026-03-26 transaction · row 3 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 3 · 2026-03-26 · Sale · Disposed 21,386 · Balance 5,107,954 F6: The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $17.07 to $18.06 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote. F7: Consists of (i) 1,100,485 shares held by VHCP3; (ii) 110,085 shares held by VHCP Co-3; and (iii) 3,897,384 shares held by VHCP EG. F3: VHCP Management III, LLC ("VHCPM3") is the general partner of VHCP3 and the manager of VHCP Co-3 and may be deemed to beneficially own these securities. VHCP Management EG, LLC ("VHCPMEG") is the general partner of VHCPEG and may be deemed to beneficially own these securities. Bong Koh and Nimish Shah are the voting members of VHCPM3 and VHCPMEG and may be deemed to beneficially own these securities. Each of VHCPM3, VHCPMEG and Messrs. Koh and Shah expressly disclaims beneficial ownership over these securities except to the extent of its or his indirect pecuniary interest therein.
Common StockSEC Table I · non-derivative	IndirectBy Funds	5,092,537	Reported balance After 2026-03-26 transaction · row 4 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 4 · 2026-03-26 · Sale · Disposed 15,417 · Balance 5,092,537 F8: The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $18.07 to $19.06 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote. F9: Consists of (i) 1,097,164 shares held by VHCP3; (ii) 109,752 shares held by VHCP Co-3; and (iii) 3,885,621 shares held by VHCP EG. F3: VHCP Management III, LLC ("VHCPM3") is the general partner of VHCP3 and the manager of VHCP Co-3 and may be deemed to beneficially own these securities. VHCP Management EG, LLC ("VHCPMEG") is the general partner of VHCPEG and may be deemed to beneficially own these securities. Bong Koh and Nimish Shah are the voting members of VHCPM3 and VHCPMEG and may be deemed to beneficially own these securities. Each of VHCPM3, VHCPMEG and Messrs. Koh and Shah expressly disclaims beneficial ownership over these securities except to the extent of its or his indirect pecuniary interest therein.
Common StockSEC Table I · non-derivative	IndirectBy Funds	5,089,354	Reported balance After 2026-03-26 transaction · row 5 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 5 · 2026-03-26 · Sale · Disposed 3,183 · Balance 5,089,354 F10: The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $19.07 to $19.25 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote. F11: Consists of (i) 1,096,478 shares held by VHCP3; (ii) 109,684 shares held by VHCP Co-3; and (iii) 3,883,192 shares held by VHCP EG. F3: VHCP Management III, LLC ("VHCPM3") is the general partner of VHCP3 and the manager of VHCP Co-3 and may be deemed to beneficially own these securities. VHCP Management EG, LLC ("VHCPMEG") is the general partner of VHCPEG and may be deemed to beneficially own these securities. Bong Koh and Nimish Shah are the voting members of VHCPM3 and VHCPMEG and may be deemed to beneficially own these securities. Each of VHCPM3, VHCPMEG and Messrs. Koh and Shah expressly disclaims beneficial ownership over these securities except to the extent of its or his indirect pecuniary interest therein.

Filing footnotes · ownership attribution and instrument terms

F1: The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $16.51 to $17.50 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.

F2: Consists of (i) 1,105,126 shares held by Venrock Healthcare Capital Partners III, L.P. ("VHCP3"); (ii) 110,550 shares held by VHCP Co-Investment Holdings III,LLC ("VHCP Co-3"); and (iii) 3,913,824 shares held by Venrock Healthcare Capital Partners EG, L.P. ("VHCP EG").

F4: The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $17.51 to $17.55 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.

F5: Consists of (i) 1,105,092 shares held by VHCP3; (ii) 110,547 shares held by VHCP Co-3; and (iii) 3,913,701 shares held by VHCP EG.

F6: The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $17.07 to $18.06 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.

F7: Consists of (i) 1,100,485 shares held by VHCP3; (ii) 110,085 shares held by VHCP Co-3; and (iii) 3,897,384 shares held by VHCP EG.

F8: The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $18.07 to $19.06 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.

F9: Consists of (i) 1,097,164 shares held by VHCP3; (ii) 109,752 shares held by VHCP Co-3; and (iii) 3,885,621 shares held by VHCP EG.

F10: The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $19.07 to $19.25 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.

F11: Consists of (i) 1,096,478 shares held by VHCP3; (ii) 109,684 shares held by VHCP Co-3; and (iii) 3,883,192 shares held by VHCP EG.

Tricida, Inc.

Report date October 24, 2022 · Filed October 26, 2022

Jointly reported with Venrock Healthcare Capital Partners II, L.P., VHCP Co-Investment Holdings II, LLC, VHCP Management II, LLC, Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, VHCP Management III, LLC, Venrock Healthcare Capital Partners EG, L.P., Koh Bong Y, Shah Nimish P

Section 16 reporting ended · disclosed 2022-10-26. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	IndirectBy Funds	3,751,406	Last balance in matching sequence After 2022-10-26 transaction · row 3 Source-order balances reconcile. Account continuity and personal attribution are not independently verified. 3 source rows Row 1 · 2022-10-24 · Sale · Disposed 2,113,948 · Balance 8,088,998 F1: Consists of (i) 202,708 shares sold by Venrock Healthcare Capital Partners II, L.P. ("VHCP II"), (ii) 82,148 shares sold by VHCP Co-Investment Holdings II, LLC ("VHCP Co-2"), (iii) 617,948 shares sold by Venrock Healthcare Capital Partners III, L.P. ("VHCP III"), (iv) 61,806 shares sold by VHCP Co-Investment Holdings III, LLC ("VHCP Co-3") and (v) 1,149,338 shares sold by Venrock Healthcare Capital Partners EG, L.P. ("VHCP EG"). F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.59 to $0.63, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3: VHCP Management II, LLC ("VHCPM II") is the general partner of Venrock Healthcare Capital Partners II, L.P. ("VHCP II") and the manager of VHCP Co-Investment Holdings II, LLC ("VHCP Co-2"). VHCP Management III, LLC ("VHCPM III") is the general partner of VHCP III and the manager of VHCP Co-3. VHCP Management EG, LLC ("VHCPM EG") is the general partner of VHCP EG. Messrs. Shah and Koh are the voting members of VHCPM II, VHCPM III and VHCPM EG. Each of VHCPM II, VHCPM III, VHCPM EG, Shah and Koh expressly disclaims beneficial ownership over all shares held by VHCP II, VHCP Co-2, VHCP III, VHCP Co-3 and VHCP EG except to the extent of its or his indirect pecuniary interest therein. Row 2 · 2022-10-25 · Sale · Disposed 1,970,418 · Balance 6,118,580 F4: The shares sold on October 25, 2022 consist of (i) 188,945 shares sold by VHCP II, (ii) 76,569 shares sold by VHCP Co-2, (iii) 575,992 shares sold by VHCP III, (iv) 57,610 shares sold by VHCP Co-3 and (v) 1,071,302 shares sold by VHCP EG. F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.52 to $0.64, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3: VHCP Management II, LLC ("VHCPM II") is the general partner of Venrock Healthcare Capital Partners II, L.P. ("VHCP II") and the manager of VHCP Co-Investment Holdings II, LLC ("VHCP Co-2"). VHCP Management III, LLC ("VHCPM III") is the general partner of VHCP III and the manager of VHCP Co-3. VHCP Management EG, LLC ("VHCPM EG") is the general partner of VHCP EG. Messrs. Shah and Koh are the voting members of VHCPM II, VHCPM III and VHCPM EG. Each of VHCPM II, VHCPM III, VHCPM EG, Shah and Koh expressly disclaims beneficial ownership over all shares held by VHCP II, VHCP Co-2, VHCP III, VHCP Co-3 and VHCP EG except to the extent of its or his indirect pecuniary interest therein. Row 3 · 2022-10-26 · Sale · Disposed 2,367,174 · Balance 3,751,406 F6: The shares sold on October 26, 2022 consist of (i) 226,991 shares sold by VHCP II, (ii) 91,988 shares sold by VHCP Co-2, (iii) 691,971 shares sold by VHCP III, (iv) 69,208 shares sold by VHCP Co-3 and (v) 1,287,016 shares sold by VHCP EG. F7: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.43 to $0.53, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3: VHCP Management II, LLC ("VHCPM II") is the general partner of Venrock Healthcare Capital Partners II, L.P. ("VHCP II") and the manager of VHCP Co-Investment Holdings II, LLC ("VHCP Co-2"). VHCP Management III, LLC ("VHCPM III") is the general partner of VHCP III and the manager of VHCP Co-3. VHCP Management EG, LLC ("VHCPM EG") is the general partner of VHCP EG. Messrs. Shah and Koh are the voting members of VHCPM II, VHCPM III and VHCPM EG. Each of VHCPM II, VHCPM III, VHCPM EG, Shah and Koh expressly disclaims beneficial ownership over all shares held by VHCP II, VHCP Co-2, VHCP III, VHCP Co-3 and VHCP EG except to the extent of its or his indirect pecuniary interest therein.

Filing footnotes · ownership attribution and instrument terms

F1: Consists of (i) 202,708 shares sold by Venrock Healthcare Capital Partners II, L.P. ("VHCP II"), (ii) 82,148 shares sold by VHCP Co-Investment Holdings II, LLC ("VHCP Co-2"), (iii) 617,948 shares sold by Venrock Healthcare Capital Partners III, L.P. ("VHCP III"), (iv) 61,806 shares sold by VHCP Co-Investment Holdings III, LLC ("VHCP Co-3") and (v) 1,149,338 shares sold by Venrock Healthcare Capital Partners EG, L.P. ("VHCP EG").

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.59 to $0.63, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F3: VHCP Management II, LLC ("VHCPM II") is the general partner of Venrock Healthcare Capital Partners II, L.P. ("VHCP II") and the manager of VHCP Co-Investment Holdings II, LLC ("VHCP Co-2"). VHCP Management III, LLC ("VHCPM III") is the general partner of VHCP III and the manager of VHCP Co-3. VHCP Management EG, LLC ("VHCPM EG") is the general partner of VHCP EG. Messrs. Shah and Koh are the voting members of VHCPM II, VHCPM III and VHCPM EG. Each of VHCPM II, VHCPM III, VHCPM EG, Shah and Koh expressly disclaims beneficial ownership over all shares held by VHCP II, VHCP Co-2, VHCP III, VHCP Co-3 and VHCP EG except to the extent of its or his indirect pecuniary interest therein.

F4: The shares sold on October 25, 2022 consist of (i) 188,945 shares sold by VHCP II, (ii) 76,569 shares sold by VHCP Co-2, (iii) 575,992 shares sold by VHCP III, (iv) 57,610 shares sold by VHCP Co-3 and (v) 1,071,302 shares sold by VHCP EG.

F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.52 to $0.64, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F6: The shares sold on October 26, 2022 consist of (i) 226,991 shares sold by VHCP II, (ii) 91,988 shares sold by VHCP Co-2, (iii) 691,971 shares sold by VHCP III, (iv) 69,208 shares sold by VHCP Co-3 and (v) 1,287,016 shares sold by VHCP EG.

F7: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.43 to $0.53, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Vistagen Therapeutics, Inc.

Report date July 12, 2022 · Filed July 14, 2022

Section 16 reporting ended · disclosed 2022-07-14. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	IndirectBy Funds	20,637,286	Reported balance After 2022-07-12 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 1 · 2022-07-12 · Sale · Disposed 60,000 · Balance 20,637,286 F1: Consists of 14,348 shares sold by Venrock Healthcare Capital Partners II, L.P. ("VHCP II"), 5,814 shares sold by VHCP Co-Investment Holdings II, LLC ("VHCP II Co"), 4,688 shares sold by Venrock Healthcare Capital Partners III, L.P. ("VHCP III"), 469 shares sold by VHCP Co-Investment Holdings III, LLC ("VHCP III Co") and 34,681 shares sold by Venrock Healthcare Capital Partners EG, L.P. ("VHCP EG"). F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.86 to $0.91, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3: Consists of 4,935,020 shares held by VHCP II, 1,999,971 shares held by VHCP II Co, 1,612,582 shares held by VHCP III, 161,351 shares held by VHCP III Co and 11,928,362 shares held by VHCP EG. F4: VHCP Management II, LLC ("VHCPM II") is the sole general partner of VHCP II and the sole manager of VHCP II Co. VHCP Management III, LLC ("VHCPM III") is the sole general partner of VHCP III and the sole manager of VHCP III Co. VHCP Management EG, LLC ("VHCPM EG") is the sole general partner of VHCP EG. Dr. Bong Koh and Nimish Shah are the voting members of VHCPM II, VHCPM III and VHCPM EG. Dr. Koh, Mr. Shah, VHCPM II, VHCPM III and VHCPM EG disclaim beneficial ownership over all shares held by VHCP II, VHCP II Co, VHCP III, VHCP III Co and VHCP EG, except to the extent of their respective indirect pecuniary interests therein.

Filing footnotes · ownership attribution and instrument terms

F1: Consists of 14,348 shares sold by Venrock Healthcare Capital Partners II, L.P. ("VHCP II"), 5,814 shares sold by VHCP Co-Investment Holdings II, LLC ("VHCP II Co"), 4,688 shares sold by Venrock Healthcare Capital Partners III, L.P. ("VHCP III"), 469 shares sold by VHCP Co-Investment Holdings III, LLC ("VHCP III Co") and 34,681 shares sold by Venrock Healthcare Capital Partners EG, L.P. ("VHCP EG").

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.86 to $0.91, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F3: Consists of 4,935,020 shares held by VHCP II, 1,999,971 shares held by VHCP II Co, 1,612,582 shares held by VHCP III, 161,351 shares held by VHCP III Co and 11,928,362 shares held by VHCP EG.

F4: VHCP Management II, LLC ("VHCPM II") is the sole general partner of VHCP II and the sole manager of VHCP II Co. VHCP Management III, LLC ("VHCPM III") is the sole general partner of VHCP III and the sole manager of VHCP III Co. VHCP Management EG, LLC ("VHCPM EG") is the sole general partner of VHCP EG. Dr. Bong Koh and Nimish Shah are the voting members of VHCPM II, VHCPM III and VHCPM EG. Dr. Koh, Mr. Shah, VHCPM II, VHCPM III and VHCPM EG disclaim beneficial ownership over all shares held by VHCP II, VHCP II Co, VHCP III, VHCP III Co and VHCP EG, except to the extent of their respective indirect pecuniary interests therein.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
October 13, 2022 Filed Oct 17, 2022 17:26 UTC	Tricida, Inc. TCDA · Entity 122050	PurchaseCommon Stock	4,674	$11.98	$55,994.52	Disclosure SEC source: 0001209191-22-053863 · doc4.xml · nonDerivative · entry 1 Venrock Healthcare Capital Partners II, L.P. · CIK 0001602264 · 10% owner VHCP Co-Investment Holdings II, LLC · CIK 0001615983 · 10% owner VHCP Management II, LLC · CIK 0001602263 · 10% owner Venrock Healthcare Capital Partners III, L.P. · CIK 0001738048 · 10% owner VHCP Co-Investment Holdings III, LLC · CIK 0001750761 · 10% owner VHCP Management III, LLC · CIK 0001738053 · 10% owner Venrock Healthcare Capital Partners EG, L.P. · CIK 0001808512 · 10% owner VHCP Management EG, LLC · CIK 0001808518 · 10% owner Koh Bong Y · CIK 0001615979 · 10% owner Shah Nimish P · CIK 0001698082 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Funds Disclosed balance after: 9,680,788 F1 · shares: Consists of (i) 1,229 shares purchased by Venrock Healthcare Capital Partners III, L.P. ("VHCP III"), (ii) 123 shares purchased by VHCP Co-Investment Holdings III, LLC ("VHCP Co-3") and (iii) 3,322 shares purchased by Venrock Healthcare Capital Partners EG, L.P. ("VHCP EG"). F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.84 to $12.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: VHCP Management II, LLC ("VHCPM II") is the general partner of Venrock Healthcare Capital Partners II, L.P. ("VHCP II") and the manager of VHCP Co-Investment Holdings II, LLC ("VHCP Co-2"). VHCP Management III, LLC ("VHCPM III") is the general partner of VHCP III and the manager of VHCP Co-3. VHCP Management EG, LLC ("VHCPM EG") is the general partner of VHCP EG. Messrs. Shah and Koh are the voting members of VHCPM II, VHCPM III and VHCPM EG. Each of VHCPM II, VHCPM III, VHCPM EG, Shah and Koh expressly disclaims beneficial ownership over all shares held by VHCP II, VHCP Co-2, VHCP III, VHCP Co-3 and VHCP EG except to the extent of its or his indirect pecuniary interest therein. Read SEC document
October 11, 2022 Filed Oct 11, 2022 18:13 UTC	Tricida, Inc. TCDA · Entity 122050	PurchaseCommon Stock	25,000	$11.85	$296,250.00	Disclosure SEC source: 0001209191-22-053374 · doc4.xml · nonDerivative · entry 3 Venrock Healthcare Capital Partners II, L.P. · CIK 0001602264 · 10% owner VHCP Co-Investment Holdings II, LLC · CIK 0001615983 · 10% owner VHCP Management II, LLC · CIK 0001602263 · 10% owner Venrock Healthcare Capital Partners III, L.P. · CIK 0001738048 · 10% owner VHCP Co-Investment Holdings III, LLC · CIK 0001750761 · 10% owner VHCP Management III, LLC · CIK 0001738053 · 10% owner Venrock Healthcare Capital Partners EG, L.P. · CIK 0001808512 · 10% owner VHCP Management EG, LLC · CIK 0001808518 · 10% owner Koh Bong Y · CIK 0001615979 · 10% owner Shah Nimish P · CIK 0001698082 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Funds Disclosed balance after: 9,676,114 F5 · shares: Consists of (i) 6,573 shares purchased by VHCP III, (ii) 658 shares purchased by VHCP Co-3 and (iii) 17,769 shares purchased by VHCP EG. F2 · ownership.nature: VHCP Management II, LLC ("VHCPM II") is the general partner of Venrock Healthcare Capital Partners II, L.P. ("VHCP II") and the manager of VHCP Co-Investment Holdings II, LLC ("VHCP Co-2"). VHCP Management III, LLC ("VHCPM III") is the general partner of VHCP III and the manager of VHCP Co-3. VHCP Management EG, LLC ("VHCPM EG") is the general partner of VHCP EG. Messrs. Shah and Koh are the voting members of VHCPM II, VHCPM III and VHCPM EG. Each of VHCPM II, VHCPM III, VHCPM EG, Shah and Koh expressly disclaims beneficial ownership over all shares held by VHCP II, VHCP Co-2, VHCP III, VHCP Co-3 and VHCP EG except to the extent of its or his indirect pecuniary interest therein. Read SEC document
October 10, 2022 Filed Oct 11, 2022 18:13 UTC	Tricida, Inc. TCDA · Entity 122050	PurchaseCommon Stock	80,314	$11.89	$954,933.46	Disclosure SEC source: 0001209191-22-053374 · doc4.xml · nonDerivative · entry 2 Venrock Healthcare Capital Partners II, L.P. · CIK 0001602264 · 10% owner VHCP Co-Investment Holdings II, LLC · CIK 0001615983 · 10% owner VHCP Management II, LLC · CIK 0001602263 · 10% owner Venrock Healthcare Capital Partners III, L.P. · CIK 0001738048 · 10% owner VHCP Co-Investment Holdings III, LLC · CIK 0001750761 · 10% owner VHCP Management III, LLC · CIK 0001738053 · 10% owner Venrock Healthcare Capital Partners EG, L.P. · CIK 0001808512 · 10% owner VHCP Management EG, LLC · CIK 0001808518 · 10% owner Koh Bong Y · CIK 0001615979 · 10% owner Shah Nimish P · CIK 0001698082 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Funds Disclosed balance after: 9,651,114 F3 · shares: Consists of (i) 21,115 shares purchased by VHCP III, (ii) 2,112 shares purchased by VHCP Co-3 and (iii) 57,087 shares purchased by VHCP EG. F4 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.36 to $12.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. F2 · ownership.nature: VHCP Management II, LLC ("VHCPM II") is the general partner of Venrock Healthcare Capital Partners II, L.P. ("VHCP II") and the manager of VHCP Co-Investment Holdings II, LLC ("VHCP Co-2"). VHCP Management III, LLC ("VHCPM III") is the general partner of VHCP III and the manager of VHCP Co-3. VHCP Management EG, LLC ("VHCPM EG") is the general partner of VHCP EG. Messrs. Shah and Koh are the voting members of VHCPM II, VHCPM III and VHCPM EG. Each of VHCPM II, VHCPM III, VHCPM EG, Shah and Koh expressly disclaims beneficial ownership over all shares held by VHCP II, VHCP Co-2, VHCP III, VHCP Co-3 and VHCP EG except to the extent of its or his indirect pecuniary interest therein. Read SEC document
October 07, 2022 Filed Oct 11, 2022 18:13 UTC	Tricida, Inc. TCDA · Entity 122050	PurchaseCommon Stock	28,900	$12.00	$346,800.00	Disclosure SEC source: 0001209191-22-053374 · doc4.xml · nonDerivative · entry 1 Venrock Healthcare Capital Partners II, L.P. · CIK 0001602264 · 10% owner VHCP Co-Investment Holdings II, LLC · CIK 0001615983 · 10% owner VHCP Management II, LLC · CIK 0001602263 · 10% owner Venrock Healthcare Capital Partners III, L.P. · CIK 0001738048 · 10% owner VHCP Co-Investment Holdings III, LLC · CIK 0001750761 · 10% owner VHCP Management III, LLC · CIK 0001738053 · 10% owner Venrock Healthcare Capital Partners EG, L.P. · CIK 0001808512 · 10% owner VHCP Management EG, LLC · CIK 0001808518 · 10% owner Koh Bong Y · CIK 0001615979 · 10% owner Shah Nimish P · CIK 0001698082 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Funds Disclosed balance after: 9,570,800 F1 · shares: Consists of (i) 7,598 shares purchased by Venrock Healthcare Capital Partners III, L.P. ("VHCP III"), (ii) 760 shares purchased by VHCP Co-Investment Holdings III, LLC ("VHCP Co-3") and (iii) 20,542 shares purchased by Venrock Healthcare Capital Partners EG, L.P. ("VHCP EG"). F2 · ownership.nature: VHCP Management II, LLC ("VHCPM II") is the general partner of Venrock Healthcare Capital Partners II, L.P. ("VHCP II") and the manager of VHCP Co-Investment Holdings II, LLC ("VHCP Co-2"). VHCP Management III, LLC ("VHCPM III") is the general partner of VHCP III and the manager of VHCP Co-3. VHCP Management EG, LLC ("VHCPM EG") is the general partner of VHCP EG. Messrs. Shah and Koh are the voting members of VHCPM II, VHCPM III and VHCPM EG. Each of VHCPM II, VHCPM III, VHCPM EG, Shah and Koh expressly disclaims beneficial ownership over all shares held by VHCP II, VHCP Co-2, VHCP III, VHCP Co-3 and VHCP EG except to the extent of its or his indirect pecuniary interest therein. Read SEC document
October 04, 2022 Filed Oct 6, 2022 16:50 UTC	Tricida, Inc. TCDA · Entity 122050	PurchaseCommon Stock	223,100	$11.81	$2,634,811.00	Disclosure SEC source: 0001209191-22-052991 · doc4.xml · nonDerivative · entry 1 Venrock Healthcare Capital Partners II, L.P. · CIK 0001602264 · 10% owner VHCP Co-Investment Holdings II, LLC · CIK 0001615983 · 10% owner VHCP Management II, LLC · CIK 0001602263 · 10% owner Venrock Healthcare Capital Partners III, L.P. · CIK 0001738048 · 10% owner VHCP Co-Investment Holdings III, LLC · CIK 0001750761 · 10% owner VHCP Management III, LLC · CIK 0001738053 · 10% owner Venrock Healthcare Capital Partners EG, L.P. · CIK 0001808512 · 10% owner VHCP Management EG, LLC · CIK 0001808518 · 10% owner Koh Bong Y · CIK 0001615979 · 10% owner Shah Nimish P · CIK 0001698082 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Funds Disclosed balance after: 9,541,900 F1 · shares: Consists of (i) 58,653 shares purchased by Venrock Healthcare Capital Partners III, L.P. ("VHCP III"), (ii) 5,867 shares purchased by VHCP Co-Investment Holdings III, LLC ("VHCP Co-3") and (iii) 158,580 shares purchased by Venrock Healthcare Capital Partners EG, L.P. ("VHCP EG"). F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.30 to $11.93, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: VHCP Management II, LLC ("VHCPM II") is the general partner of Venrock Healthcare Capital Partners II, L.P. ("VHCP II") and the manager of VHCP Co-Investment Holdings II, LLC ("VHCP Co-2"). VHCP Management III, LLC ("VHCPM III") is the general partner of VHCP III and the manager of VHCP Co-3. VHCP Management EG, LLC ("VHCPM EG") is the general partner of VHCP EG. Messrs. Shah and Koh are the voting members of VHCPM II, VHCPM III and VHCPM EG. Each of VHCPM II, VHCPM III, VHCPM EG, Shah and Koh expressly disclaims beneficial ownership over all shares held by VHCP II, VHCP Co-2, VHCP III, VHCP Co-3 and VHCP EG except to the extent of its or his indirect pecuniary interest therein. Read SEC document
October 03, 2022 Filed Oct 3, 2022 17:49 UTC	Tricida, Inc. TCDA · Entity 122050	PurchaseCommon Stock	268,736	$11.27	$3,028,654.72	Disclosure SEC source: 0001209191-22-051925 · doc4.xml · nonDerivative · entry 2 Venrock Healthcare Capital Partners II, L.P. · CIK 0001602264 · 10% owner VHCP Co-Investment Holdings II, LLC · CIK 0001615983 · 10% owner VHCP Management II, LLC · CIK 0001602263 · 10% owner Venrock Healthcare Capital Partners III, L.P. · CIK 0001738048 · 10% owner VHCP Co-Investment Holdings III, LLC · CIK 0001750761 · 10% owner VHCP Management III, LLC · CIK 0001738053 · 10% owner Venrock Healthcare Capital Partners EG, L.P. · CIK 0001808512 · 10% owner VHCP Management EG, LLC · CIK 0001808518 · 10% owner Koh Bong Y · CIK 0001615979 · 10% owner Shah Nimish P · CIK 0001698082 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Funds Disclosed balance after: 9,318,800 F4 · shares: Consists of (i) 70,650 shares purchased by VHCP III, (ii) 7,068 shares purchased by VHCP Co-3 and (iii) 191,018 shares purchased by VHCP EG. F5 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.80 to $11.47, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: VHCP Management II, LLC ("VHCPM II") is the general partner of Venrock Healthcare Capital Partners II, L.P. ("VHCP II") and the manager of VHCP Co-Investment Holdings II, LLC ("VHCP Co-2"). VHCP Management III, LLC ("VHCPM III") is the general partner of VHCP III and the manager of VHCP Co-3. VHCP Management EG, LLC ("VHCPM EG") is the general partner of VHCP EG. Messrs. Shah and Koh are the voting members of VHCPM II, VHCPM III and VHCPM EG. Each of VHCPM II, VHCPM III, VHCPM EG, Shah and Koh expressly disclaims beneficial ownership over all shares held by VHCP II, VHCP Co-2, VHCP III, VHCP Co-3 and VHCP EG except to the extent of its or his indirect pecuniary interest therein. Read SEC document
September 29, 2022 Filed Oct 3, 2022 17:49 UTC	Tricida, Inc. TCDA · Entity 122050	PurchaseCommon Stock	168,187	$9.92	$1,668,415.04	Disclosure SEC source: 0001209191-22-051925 · doc4.xml · nonDerivative · entry 1 Venrock Healthcare Capital Partners II, L.P. · CIK 0001602264 · 10% owner VHCP Co-Investment Holdings II, LLC · CIK 0001615983 · 10% owner VHCP Management II, LLC · CIK 0001602263 · 10% owner Venrock Healthcare Capital Partners III, L.P. · CIK 0001738048 · 10% owner VHCP Co-Investment Holdings III, LLC · CIK 0001750761 · 10% owner VHCP Management III, LLC · CIK 0001738053 · 10% owner Venrock Healthcare Capital Partners EG, L.P. · CIK 0001808512 · 10% owner VHCP Management EG, LLC · CIK 0001808518 · 10% owner Koh Bong Y · CIK 0001615979 · 10% owner Shah Nimish P · CIK 0001698082 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Funds Disclosed balance after: 9,050,064 F1 · shares: Consists of (i) 44,217 shares purchased by Venrock Healthcare Capital Partners III, L.P. ("VHCP III"), (ii) 4,422 shares purchased by VHCP Co-Investment Holdings III, LLC ("VHCP Co-3") and (iii) 119,548 shares purchased by Venrock Healthcare Capital Partners EG, L.P. ("VHCP EG"). F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.83 to $10.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: VHCP Management II, LLC ("VHCPM II") is the general partner of Venrock Healthcare Capital Partners II, L.P. ("VHCP II") and the manager of VHCP Co-Investment Holdings II, LLC ("VHCP Co-2"). VHCP Management III, LLC ("VHCPM III") is the general partner of VHCP III and the manager of VHCP Co-3. VHCP Management EG, LLC ("VHCPM EG") is the general partner of VHCP EG. Messrs. Shah and Koh are the voting members of VHCPM II, VHCPM III and VHCPM EG. Each of VHCPM II, VHCPM III, VHCPM EG, Shah and Koh expressly disclaims beneficial ownership over all shares held by VHCP II, VHCP Co-2, VHCP III, VHCP Co-3 and VHCP EG except to the extent of its or his indirect pecuniary interest therein. Read SEC document
September 28, 2022 Filed Sep 28, 2022 20:05 UTC	Tricida, Inc. TCDA · Entity 122050	PurchaseCommon Stock	76,600	$9.92	$759,872.00	Disclosure SEC source: 0001209191-22-051501 · doc4.xml · nonDerivative · entry 3 Venrock Healthcare Capital Partners II, L.P. · CIK 0001602264 · 10% owner VHCP Co-Investment Holdings II, LLC · CIK 0001615983 · 10% owner VHCP Management II, LLC · CIK 0001602263 · 10% owner Venrock Healthcare Capital Partners III, L.P. · CIK 0001738048 · 10% owner VHCP Co-Investment Holdings III, LLC · CIK 0001750761 · 10% owner VHCP Management III, LLC · CIK 0001738053 · 10% owner Venrock Healthcare Capital Partners EG, L.P. · CIK 0001808512 · 10% owner VHCP Management EG, LLC · CIK 0001808518 · 10% owner Koh Bong Y · CIK 0001615979 · 10% owner Shah Nimish P · CIK 0001698082 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Funds Disclosed balance after: 8,881,877 F6 · shares: Consists of (i) 20,138 shares purchased by VHCP III, (ii) 2,014 shares purchased by VHCP Co-3 and (iii) 54,448 shares purchased by VHCP EG. F7 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.72 to $10.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: VHCP Management II, LLC ("VHCPM II") is the general partner of Venrock Healthcare Capital Partners II, L.P. ("VHCP II") and the manager of VHCP Co-Investment Holdings II, LLC ("VHCP Co-2"). VHCP Management III, LLC ("VHCPM III") is the general partner of VHCP III and the manager of VHCP Co-3. VHCP Management EG, LLC ("VHCPM EG") is the general partner of VHCP EG. Messrs. Shah and Koh are the voting members of VHCPM II, VHCPM III and VHCPM EG. Each of VHCPM II, VHCPM III, VHCPM EG, Shah and Koh expressly disclaims beneficial ownership over all shares held by VHCP II, VHCP Co-2, VHCP III, VHCP Co-3 and VHCP EG except to the extent of its or his indirect pecuniary interest therein. Read SEC document
September 27, 2022 Filed Sep 28, 2022 20:05 UTC	Tricida, Inc. TCDA · Entity 122050	PurchaseCommon Stock	115,000	$9.38	$1,078,700.00	Disclosure SEC source: 0001209191-22-051501 · doc4.xml · nonDerivative · entry 2 Venrock Healthcare Capital Partners II, L.P. · CIK 0001602264 · 10% owner VHCP Co-Investment Holdings II, LLC · CIK 0001615983 · 10% owner VHCP Management II, LLC · CIK 0001602263 · 10% owner Venrock Healthcare Capital Partners III, L.P. · CIK 0001738048 · 10% owner VHCP Co-Investment Holdings III, LLC · CIK 0001750761 · 10% owner VHCP Management III, LLC · CIK 0001738053 · 10% owner Venrock Healthcare Capital Partners EG, L.P. · CIK 0001808512 · 10% owner VHCP Management EG, LLC · CIK 0001808518 · 10% owner Koh Bong Y · CIK 0001615979 · 10% owner Shah Nimish P · CIK 0001698082 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Funds Disclosed balance after: 8,805,277 F4 · shares: Consists of (i) 30,234 shares purchased by VHCP III, (ii) 3,024 shares purchased by VHCP Co-3 and (iii) 81,742 shares purchased by VHCP EG. F5 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.22 to $9.57, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: VHCP Management II, LLC ("VHCPM II") is the general partner of Venrock Healthcare Capital Partners II, L.P. ("VHCP II") and the manager of VHCP Co-Investment Holdings II, LLC ("VHCP Co-2"). VHCP Management III, LLC ("VHCPM III") is the general partner of VHCP III and the manager of VHCP Co-3. VHCP Management EG, LLC ("VHCPM EG") is the general partner of VHCP EG. Messrs. Shah and Koh are the voting members of VHCPM II, VHCPM III and VHCPM EG. Each of VHCPM II, VHCPM III, VHCPM EG, Shah and Koh expressly disclaims beneficial ownership over all shares held by VHCP II, VHCP Co-2, VHCP III, VHCP Co-3 and VHCP EG except to the extent of its or his indirect pecuniary interest therein. Read SEC document
September 26, 2022 Filed Sep 28, 2022 20:05 UTC	Tricida, Inc. TCDA · Entity 122050	PurchaseCommon Stock	395,614	$8.56	$3,386,455.84	Disclosure SEC source: 0001209191-22-051501 · doc4.xml · nonDerivative · entry 1 Venrock Healthcare Capital Partners II, L.P. · CIK 0001602264 · 10% owner VHCP Co-Investment Holdings II, LLC · CIK 0001615983 · 10% owner VHCP Management II, LLC · CIK 0001602263 · 10% owner Venrock Healthcare Capital Partners III, L.P. · CIK 0001738048 · 10% owner VHCP Co-Investment Holdings III, LLC · CIK 0001750761 · 10% owner VHCP Management III, LLC · CIK 0001738053 · 10% owner Venrock Healthcare Capital Partners EG, L.P. · CIK 0001808512 · 10% owner VHCP Management EG, LLC · CIK 0001808518 · 10% owner Koh Bong Y · CIK 0001615979 · 10% owner Shah Nimish P · CIK 0001698082 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Funds Disclosed balance after: 8,690,277 F1 · shares: Consists of (i) 104,007 shares purchased by Venrock Healthcare Capital Partners III, L.P. ("VHCP III"), (ii) 10,405 shares purchased by VHCP Co-Investment Holdings III, LLC ("VHCP Co-3") and (iii) 281,202 shares purchased by Venrock Healthcare Capital Partners EG, L.P. ("VHCP EG"). F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.33 to $8.73, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: VHCP Management II, LLC ("VHCPM II") is the general partner of Venrock Healthcare Capital Partners II, L.P. ("VHCP II") and the manager of VHCP Co-Investment Holdings II, LLC ("VHCP Co-2"). VHCP Management III, LLC ("VHCPM III") is the general partner of VHCP III and the manager of VHCP Co-3. VHCP Management EG, LLC ("VHCPM EG") is the general partner of VHCP EG. Messrs. Shah and Koh are the voting members of VHCPM II, VHCPM III and VHCPM EG. Each of VHCPM II, VHCPM III, VHCPM EG, Shah and Koh expressly disclaims beneficial ownership over all shares held by VHCP II, VHCP Co-2, VHCP III, VHCP Co-3 and VHCP EG except to the extent of its or his indirect pecuniary interest therein. Read SEC document
September 07, 2022 Filed Sep 7, 2022 16:12 UTC	Tricida, Inc. TCDA · Entity 122050	PurchaseCommon Stock	473,459	$11.40	$5,397,432.60	Disclosure SEC source: 0001209191-22-048998 · doc4.xml · nonDerivative · entry 3 Venrock Healthcare Capital Partners II, L.P. · CIK 0001602264 · 10% owner VHCP Co-Investment Holdings II, LLC · CIK 0001615983 · 10% owner VHCP Management II, LLC · CIK 0001602263 · 10% owner Venrock Healthcare Capital Partners III, L.P. · CIK 0001738048 · 10% owner VHCP Co-Investment Holdings III, LLC · CIK 0001750761 · 10% owner VHCP Management III, LLC · CIK 0001738053 · 10% owner Venrock Healthcare Capital Partners EG, L.P. · CIK 0001808512 · 10% owner VHCP Management EG, LLC · CIK 0001808518 · 10% owner Koh Bong Y · CIK 0001615979 · 10% owner Shah Nimish P · CIK 0001698082 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Funds Disclosed balance after: 8,294,663 F6 · shares: Consists of (i) 124,472 shares purchased by VHCP III, (ii) 12,452 shares purchased by VHCP Co-3 and (iii) 336,535 shares purchased by VHCP EG. F7 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.40 to $11.75, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: VHCP Management II, LLC ("VHCPM II") is the general partner of Venrock Healthcare Capital Partners II, L.P. ("VHCP II") and the manager of VHCP Co-Investment Holdings II, LLC ("VHCP Co-2"). VHCP Management III, LLC ("VHCPM III") is the general partner of VHCP III and the manager of VHCP Co-3. VHCP Management EG, LLC ("VHCPM EG") is the general partner of VHCP EG. Messrs. Shah and Koh are the voting members of VHCPM II, VHCPM III and VHCPM EG. Each of VHCPM II, VHCPM III, VHCPM EG, Shah and Koh expressly disclaims beneficial ownership over all shares held by VHCP II, VHCP Co-2, VHCP III, VHCP Co-3 and VHCP EG except to the extent of its or his indirect pecuniary interest therein. Read SEC document
September 06, 2022 Filed Sep 7, 2022 16:12 UTC	Tricida, Inc. TCDA · Entity 122050	PurchaseCommon Stock	150,223	$11.43	$1,717,048.89	Disclosure SEC source: 0001209191-22-048998 · doc4.xml · nonDerivative · entry 2 Venrock Healthcare Capital Partners II, L.P. · CIK 0001602264 · 10% owner VHCP Co-Investment Holdings II, LLC · CIK 0001615983 · 10% owner VHCP Management II, LLC · CIK 0001602263 · 10% owner Venrock Healthcare Capital Partners III, L.P. · CIK 0001738048 · 10% owner VHCP Co-Investment Holdings III, LLC · CIK 0001750761 · 10% owner VHCP Management III, LLC · CIK 0001738053 · 10% owner Venrock Healthcare Capital Partners EG, L.P. · CIK 0001808512 · 10% owner VHCP Management EG, LLC · CIK 0001808518 · 10% owner Koh Bong Y · CIK 0001615979 · 10% owner Shah Nimish P · CIK 0001698082 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Funds Disclosed balance after: 7,821,204 F4 · shares: Consists of (i) 39,493 shares purchased by VHCP III, (ii) 3,951 shares purchased by VHCP Co-3 and (iii) 106,779 shares purchased by VHCP EG. F5 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.10 to $12.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: VHCP Management II, LLC ("VHCPM II") is the general partner of Venrock Healthcare Capital Partners II, L.P. ("VHCP II") and the manager of VHCP Co-Investment Holdings II, LLC ("VHCP Co-2"). VHCP Management III, LLC ("VHCPM III") is the general partner of VHCP III and the manager of VHCP Co-3. VHCP Management EG, LLC ("VHCPM EG") is the general partner of VHCP EG. Messrs. Shah and Koh are the voting members of VHCPM II, VHCPM III and VHCPM EG. Each of VHCPM II, VHCPM III, VHCPM EG, Shah and Koh expressly disclaims beneficial ownership over all shares held by VHCP II, VHCP Co-2, VHCP III, VHCP Co-3 and VHCP EG except to the extent of its or his indirect pecuniary interest therein. Read SEC document
September 02, 2022 Filed Sep 7, 2022 16:12 UTC	Tricida, Inc. TCDA · Entity 122050	PurchaseCommon Stock	63,030	$12.76	$804,262.80	Disclosure SEC source: 0001209191-22-048998 · doc4.xml · nonDerivative · entry 1 Venrock Healthcare Capital Partners II, L.P. · CIK 0001602264 · 10% owner VHCP Co-Investment Holdings II, LLC · CIK 0001615983 · 10% owner VHCP Management II, LLC · CIK 0001602263 · 10% owner Venrock Healthcare Capital Partners III, L.P. · CIK 0001738048 · 10% owner VHCP Co-Investment Holdings III, LLC · CIK 0001750761 · 10% owner VHCP Management III, LLC · CIK 0001738053 · 10% owner Venrock Healthcare Capital Partners EG, L.P. · CIK 0001808512 · 10% owner VHCP Management EG, LLC · CIK 0001808518 · 10% owner Koh Bong Y · CIK 0001615979 · 10% owner Shah Nimish P · CIK 0001698082 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Funds Disclosed balance after: 7,670,981 F1 · shares: Consists of (i) 16,571 shares purchased by Venrock Healthcare Capital Partners III, L.P. ("VHCP III"), (ii) 1,658 shares purchased by VHCP Co-Investment Holdings III, LLC ("VHCP Co-3") and (iii) 44,801 shares purchased by Venrock Healthcare Capital Partners EG, L.P. ("VHCP EG"). F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.48 to $12.99, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: VHCP Management II, LLC ("VHCPM II") is the general partner of Venrock Healthcare Capital Partners II, L.P. ("VHCP II") and the manager of VHCP Co-Investment Holdings II, LLC ("VHCP Co-2"). VHCP Management III, LLC ("VHCPM III") is the general partner of VHCP III and the manager of VHCP Co-3. VHCP Management EG, LLC ("VHCPM EG") is the general partner of VHCP EG. Messrs. Shah and Koh are the voting members of VHCPM II, VHCPM III and VHCPM EG. Each of VHCPM II, VHCPM III, VHCPM EG, Shah and Koh expressly disclaims beneficial ownership over all shares held by VHCP II, VHCP Co-2, VHCP III, VHCP Co-3 and VHCP EG except to the extent of its or his indirect pecuniary interest therein. Read SEC document
August 30, 2022 Filed Sep 1, 2022 16:18 UTC	Tricida, Inc. TCDA · Entity 122050	PurchaseCommon Stock	50,000	$12.20	$610,000.00	Disclosure SEC source: 0001209191-22-048246 · doc4.xml · nonDerivative · entry 1 Venrock Healthcare Capital Partners II, L.P. · CIK 0001602264 · 10% owner VHCP Co-Investment Holdings II, LLC · CIK 0001615983 · 10% owner VHCP Management II, LLC · CIK 0001602263 · 10% owner Venrock Healthcare Capital Partners III, L.P. · CIK 0001738048 · 10% owner VHCP Co-Investment Holdings III, LLC · CIK 0001750761 · 10% owner VHCP Management III, LLC · CIK 0001738053 · 10% owner Venrock Healthcare Capital Partners EG, L.P. · CIK 0001808512 · 10% owner VHCP Management EG, LLC · CIK 0001808518 · 10% owner Koh Bong Y · CIK 0001615979 · 10% owner Shah Nimish P · CIK 0001698082 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Funds Disclosed balance after: 7,607,951 F1 · shares: Consists of (i) 13,145 shares purchased by Venrock Healthcare Capital Partners III, L.P. ("VHCP III"), (ii) 1,315 shares purchased by VHCP Co- Investment Holdings III, LLC ("VHCP Co-3") and (iii) 35,540 shares purchased by Venrock Healthcare Capital Partners EG, L.P. ("VHCP EG"). F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.20 to $12.23, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: VHCP Management II, LLC ("VHCPM II") is the general partner of Venrock Healthcare Capital Partners II, L.P. ("VHCP II") and the manager of VHCP Co-Investment Holdings II, LLC ("VHCP Co-2"). VHCP Management III, LLC ("VHCPM III") is the general partner of VHCP III and the manager of VHCP Co-3. VHCP Management EG, LLC ("VHCPM EG") is the general partner of VHCP EG. Messrs. Shah and Koh are the voting members of VHCPM II, VHCPM III and VHCPM EG. Each of VHCPM II, VHCPM III, VHCPM EG, Shah and Koh expressly disclaims beneficial ownership over all shares held by VHCP II, VHCP Co-2, VHCP III, VHCP Co-3 and VHCP EG except to the extent of its or his indirect pecuniary interest therein. Read SEC document
July 29, 2022 Filed Aug 2, 2022 17:32 UTC	Tricida, Inc. TCDA · Entity 122050	PurchaseCommon Stock	18,900	$9.21	$174,069.00	Disclosure SEC source: 0001209191-22-043953 · doc4.xml · nonDerivative · entry 1 Venrock Healthcare Capital Partners II, L.P. · CIK 0001602264 · 10% owner VHCP Co-Investment Holdings II, LLC · CIK 0001615983 · 10% owner VHCP Management II, LLC · CIK 0001602263 · 10% owner Venrock Healthcare Capital Partners III, L.P. · CIK 0001738048 · 10% owner VHCP Co-Investment Holdings III, LLC · CIK 0001750761 · 10% owner VHCP Management III, LLC · CIK 0001738053 · 10% owner Venrock Healthcare Capital Partners EG, L.P. · CIK 0001808512 · 10% owner VHCP Management EG, LLC · CIK 0001808518 · 10% owner Koh Bong Y · CIK 0001615979 · 10% owner Shah Nimish P · CIK 0001698082 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Funds Disclosed balance after: 7,557,951 F1 · shares: Consists of (i) 4,969 shares purchased by Venrock Healthcare Capital Partners III, L.P. ("VHCP III"), (ii) 497 shares purchased by VHCP Co-Investment Holdings III, LLC ("VHCP Co-3") and (iii) 13,434 shares purchased by Venrock Healthcare Capital Partners EG, L.P. ("VHCP EG"). F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.14 to $9.30, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: VHCP Management II, LLC ("VHCPM II") is the general partner of Venrock Healthcare Capital Partners II, L.P. ("VHCP II") and the manager of VHCP Co-Investment Holdings II, LLC ("VHCP Co-2"). VHCP Management III, LLC ("VHCPM III") is the general partner of VHCP III and the manager of VHCP Co-3. VHCP Management EG, LLC ("VHCPM EG") is the general partner of VHCP EG. Messrs. Shah and Koh are the voting members of VHCPM II, VHCPM III and VHCPM EG. Each of VHCPM II, VHCPM III, VHCPM EG, Shah and Koh expressly disclaims beneficial ownership over all shares held by VHCP II, VHCP Co-2, VHCP III, VHCP Co-3 and VHCP EG except to the extent of its or his indirect pecuniary interest therein. Read SEC document
July 25, 2022 Filed Jul 25, 2022 18:09 UTC	Tricida, Inc. TCDA · Entity 122050	PurchaseCommon Stock	29,199	$8.95	$261,331.05	Disclosure SEC source: 0001209191-22-043141 · doc4.xml · nonDerivative · entry 3 Venrock Healthcare Capital Partners II, L.P. · CIK 0001602264 · 10% owner VHCP Co-Investment Holdings II, LLC · CIK 0001615983 · 10% owner VHCP Management II, LLC · CIK 0001602263 · 10% owner Venrock Healthcare Capital Partners III, L.P. · CIK 0001738048 · 10% owner VHCP Co-Investment Holdings III, LLC · CIK 0001750761 · 10% owner VHCP Management III, LLC · CIK 0001738053 · 10% owner Venrock Healthcare Capital Partners EG, L.P. · CIK 0001808512 · 10% owner VHCP Management EG, LLC · CIK 0001808518 · 10% owner Koh Bong Y · CIK 0001615979 · 10% owner Shah Nimish P · CIK 0001698082 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Funds Disclosed balance after: 7,539,051 F6 · shares: Consists of (i) 7,676 shares purchased by VHCP III, (ii) 768 shares purchased by VHCP Co-3 and (iii) 20,755 shares purchased by VHCP EG. F7 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.78 to $9.01, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: VHCP Management II, LLC ("VHCPM II") is the general partner of Venrock Healthcare Capital Partners II, L.P. ("VHCP II") and the manager of VHCP Co-Investment Holdings II, LLC ("VHCP Co-2"). VHCP Management III, LLC ("VHCPM III") is the general partner of VHCP III and the manager of VHCP Co-3. VHCP Management EG, LLC ("VHCPM EG") is the general partner of VHCP EG. Messrs. Shah and Koh are the voting members of VHCPM II, VHCPM III and VHCPM EG. Each of VHCPM II, VHCPM III, VHCPM EG, Shah and Koh expressly disclaims beneficial ownership over all shares held by VHCP II, VHCP Co-2, VHCP III, VHCP Co-3 and VHCP EG except to the extent of its or his indirect pecuniary interest therein. Read SEC document
July 22, 2022 Filed Jul 25, 2022 18:09 UTC	Tricida, Inc. TCDA · Entity 122050	PurchaseCommon Stock	15,000	$9.21	$138,150.00	Disclosure SEC source: 0001209191-22-043141 · doc4.xml · nonDerivative · entry 2 Venrock Healthcare Capital Partners II, L.P. · CIK 0001602264 · 10% owner VHCP Co-Investment Holdings II, LLC · CIK 0001615983 · 10% owner VHCP Management II, LLC · CIK 0001602263 · 10% owner Venrock Healthcare Capital Partners III, L.P. · CIK 0001738048 · 10% owner VHCP Co-Investment Holdings III, LLC · CIK 0001750761 · 10% owner VHCP Management III, LLC · CIK 0001738053 · 10% owner Venrock Healthcare Capital Partners EG, L.P. · CIK 0001808512 · 10% owner VHCP Management EG, LLC · CIK 0001808518 · 10% owner Koh Bong Y · CIK 0001615979 · 10% owner Shah Nimish P · CIK 0001698082 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Funds Disclosed balance after: 7,509,852 F4 · shares: Consists of (i) 3,944 shares purchased by VHCP III, (ii) 394 shares purchased by VHCP Co-3 and (iii) 10,662 shares purchased by VHCP EG. F5 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.00 to $9.52, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: VHCP Management II, LLC ("VHCPM II") is the general partner of Venrock Healthcare Capital Partners II, L.P. ("VHCP II") and the manager of VHCP Co-Investment Holdings II, LLC ("VHCP Co-2"). VHCP Management III, LLC ("VHCPM III") is the general partner of VHCP III and the manager of VHCP Co-3. VHCP Management EG, LLC ("VHCPM EG") is the general partner of VHCP EG. Messrs. Shah and Koh are the voting members of VHCPM II, VHCPM III and VHCPM EG. Each of VHCPM II, VHCPM III, VHCPM EG, Shah and Koh expressly disclaims beneficial ownership over all shares held by VHCP II, VHCP Co-2, VHCP III, VHCP Co-3 and VHCP EG except to the extent of its or his indirect pecuniary interest therein. Read SEC document
July 21, 2022 Filed Jul 25, 2022 18:09 UTC	Tricida, Inc. TCDA · Entity 122050	PurchaseCommon Stock	30,000	$9.59	$287,700.00	Disclosure SEC source: 0001209191-22-043141 · doc4.xml · nonDerivative · entry 1 Venrock Healthcare Capital Partners II, L.P. · CIK 0001602264 · 10% owner VHCP Co-Investment Holdings II, LLC · CIK 0001615983 · 10% owner VHCP Management II, LLC · CIK 0001602263 · 10% owner Venrock Healthcare Capital Partners III, L.P. · CIK 0001738048 · 10% owner VHCP Co-Investment Holdings III, LLC · CIK 0001750761 · 10% owner VHCP Management III, LLC · CIK 0001738053 · 10% owner Venrock Healthcare Capital Partners EG, L.P. · CIK 0001808512 · 10% owner VHCP Management EG, LLC · CIK 0001808518 · 10% owner Koh Bong Y · CIK 0001615979 · 10% owner Shah Nimish P · CIK 0001698082 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Funds Disclosed balance after: 7,494,852 F1 · shares: Consists of (i) 7,887 shares purchased by Venrock Healthcare Capital Partners III, L.P. ("VHCP III"), (ii) 789 shares purchased by VHCP Co-Investment Holdings III, LLC ("VHCP Co-3") and (iii) 21,324 shares purchased by Venrock Healthcare Capital Partners EG, L.P. ("VHCP EG"). F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.41 to $9.71, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: VHCP Management II, LLC ("VHCPM II") is the general partner of Venrock Healthcare Capital Partners II, L.P. ("VHCP II") and the manager of VHCP Co-Investment Holdings II, LLC ("VHCP Co-2"). VHCP Management III, LLC ("VHCPM III") is the general partner of VHCP III and the manager of VHCP Co-3. VHCP Management EG, LLC ("VHCPM EG") is the general partner of VHCP EG. Messrs. Shah and Koh are the voting members of VHCPM II, VHCPM III and VHCPM EG. Each of VHCPM II, VHCPM III, VHCPM EG, Shah and Koh expressly disclaims beneficial ownership over all shares held by VHCP II, VHCP Co-2, VHCP III, VHCP Co-3 and VHCP EG except to the extent of its or his indirect pecuniary interest therein. Read SEC document
July 20, 2022 Filed Jul 20, 2022 16:38 UTC	Tricida, Inc. TCDA · Entity 122050	PurchaseCommon Stock	25,000	$9.54	$238,500.00	Disclosure SEC source: 0001209191-22-042695 · doc4.xml · nonDerivative · entry 3 Venrock Healthcare Capital Partners II, L.P. · CIK 0001602264 · 10% owner VHCP Co-Investment Holdings II, LLC · CIK 0001615983 · 10% owner VHCP Management II, LLC · CIK 0001602263 · 10% owner Venrock Healthcare Capital Partners III, L.P. · CIK 0001738048 · 10% owner VHCP Co-Investment Holdings III, LLC · CIK 0001750761 · 10% owner VHCP Management III, LLC · CIK 0001738053 · 10% owner Venrock Healthcare Capital Partners EG, L.P. · CIK 0001808512 · 10% owner VHCP Management EG, LLC · CIK 0001808518 · 10% owner Koh Bong Y · CIK 0001615979 · 10% owner Shah Nimish P · CIK 0001698082 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Funds Disclosed balance after: 7,464,852 F4 · shares: Consists of (i) 6,573 shares purchased by VHCP III, (ii) 657 shares purchased by VHCP Co-3 and (iii) 17,770 shares purchased by VHCP EG. F6 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.18 to $10.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: VHCP Management II, LLC ("VHCPM II") is the general partner of Venrock Healthcare Capital Partners II, L.P. ("VHCP II") and the manager of VHCP Co-Investment Holdings II, LLC ("VHCP Co-2"). VHCP Management III, LLC ("VHCPM III") is the general partner of VHCP III and the manager of VHCP Co-3. VHCP Management EG, LLC ("VHCPM EG") is the general partner of VHCP EG. Messrs. Shah and Koh are the voting members of VHCPM II, VHCPM III and VHCPM EG. Each of VHCPM II, VHCPM III, VHCPM EG, Shah and Koh expressly disclaims beneficial ownership over all shares held by VHCP II, VHCP Co-2, VHCP III, VHCP Co-3 and VHCP EG except to the extent of its or his indirect pecuniary interest therein. Read SEC document
July 19, 2022 Filed Jul 20, 2022 16:38 UTC	Tricida, Inc. TCDA · Entity 122050	PurchaseCommon Stock	25,000	$9.47	$236,750.00	Disclosure SEC source: 0001209191-22-042695 · doc4.xml · nonDerivative · entry 2 Venrock Healthcare Capital Partners II, L.P. · CIK 0001602264 · 10% owner VHCP Co-Investment Holdings II, LLC · CIK 0001615983 · 10% owner VHCP Management II, LLC · CIK 0001602263 · 10% owner Venrock Healthcare Capital Partners III, L.P. · CIK 0001738048 · 10% owner VHCP Co-Investment Holdings III, LLC · CIK 0001750761 · 10% owner VHCP Management III, LLC · CIK 0001738053 · 10% owner Venrock Healthcare Capital Partners EG, L.P. · CIK 0001808512 · 10% owner VHCP Management EG, LLC · CIK 0001808518 · 10% owner Koh Bong Y · CIK 0001615979 · 10% owner Shah Nimish P · CIK 0001698082 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Funds Disclosed balance after: 7,439,852 F4 · shares: Consists of (i) 6,573 shares purchased by VHCP III, (ii) 657 shares purchased by VHCP Co-3 and (iii) 17,770 shares purchased by VHCP EG. F5 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.12 to $9.71, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: VHCP Management II, LLC ("VHCPM II") is the general partner of Venrock Healthcare Capital Partners II, L.P. ("VHCP II") and the manager of VHCP Co-Investment Holdings II, LLC ("VHCP Co-2"). VHCP Management III, LLC ("VHCPM III") is the general partner of VHCP III and the manager of VHCP Co-3. VHCP Management EG, LLC ("VHCPM EG") is the general partner of VHCP EG. Messrs. Shah and Koh are the voting members of VHCPM II, VHCPM III and VHCPM EG. Each of VHCPM II, VHCPM III, VHCPM EG, Shah and Koh expressly disclaims beneficial ownership over all shares held by VHCP II, VHCP Co-2, VHCP III, VHCP Co-3 and VHCP EG except to the extent of its or his indirect pecuniary interest therein. Read SEC document
July 18, 2022 Filed Jul 20, 2022 16:38 UTC	Tricida, Inc. TCDA · Entity 122050	PurchaseCommon Stock	100,000	$9.02	$902,000.00	Disclosure SEC source: 0001209191-22-042695 · doc4.xml · nonDerivative · entry 1 Venrock Healthcare Capital Partners II, L.P. · CIK 0001602264 · 10% owner VHCP Co-Investment Holdings II, LLC · CIK 0001615983 · 10% owner VHCP Management II, LLC · CIK 0001602263 · 10% owner Venrock Healthcare Capital Partners III, L.P. · CIK 0001738048 · 10% owner VHCP Co-Investment Holdings III, LLC · CIK 0001750761 · 10% owner VHCP Management III, LLC · CIK 0001738053 · 10% owner Venrock Healthcare Capital Partners EG, L.P. · CIK 0001808512 · 10% owner VHCP Management EG, LLC · CIK 0001808518 · 10% owner Koh Bong Y · CIK 0001615979 · 10% owner Shah Nimish P · CIK 0001698082 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Funds Disclosed balance after: 7,414,852 F1 · shares: Consists of (i) 26,290 shares purchased by Venrock Healthcare Capital Partners III, L.P. ("VHCP III"), (ii) 2,630 shares purchased by VHCP Co-Investment Holdings III, LLC ("VHCP Co-3") and (iii) 71,080 shares purchased by Venrock Healthcare Capital Partners EG, L.P. ("VHCP EG"). F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.91 to $9.28, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: VHCP Management II, LLC ("VHCPM II") is the general partner of Venrock Healthcare Capital Partners II, L.P. ("VHCP II") and the manager of VHCP Co-Investment Holdings II, LLC ("VHCP Co-2"). VHCP Management III, LLC ("VHCPM III") is the general partner of VHCP III and the manager of VHCP Co-3. VHCP Management EG, LLC ("VHCPM EG") is the general partner of VHCP EG. Messrs. Shah and Koh are the voting members of VHCPM II, VHCPM III and VHCPM EG. Each of VHCPM II, VHCPM III, VHCPM EG, Shah and Koh expressly disclaims beneficial ownership over all shares held by VHCP II, VHCP Co-2, VHCP III, VHCP Co-3 and VHCP EG except to the extent of its or his indirect pecuniary interest therein. Read SEC document
July 14, 2022 Filed Jul 14, 2022 17:43 UTC	Tricida, Inc. TCDA · Entity 122050	PurchaseCommon Stock	36,717	$9.85	$361,662.45	Disclosure SEC source: 0001209191-22-042154 · doc4.xml · nonDerivative · entry 3 Venrock Healthcare Capital Partners II, L.P. · CIK 0001602264 · 10% owner VHCP Co-Investment Holdings II, LLC · CIK 0001615983 · 10% owner VHCP Management II, LLC · CIK 0001602263 · 10% owner Venrock Healthcare Capital Partners III, L.P. · CIK 0001738048 · 10% owner VHCP Co-Investment Holdings III, LLC · CIK 0001750761 · 10% owner VHCP Management III, LLC · CIK 0001738053 · 10% owner Venrock Healthcare Capital Partners EG, L.P. · CIK 0001808512 · 10% owner VHCP Management EG, LLC · CIK 0001808518 · 10% owner Koh Bong Y · CIK 0001615979 · 10% owner Shah Nimish P · CIK 0001698082 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Funds Disclosed balance after: 7,314,852 F6 · shares: Consists of (i) 9,653 shares purchased by VHCP III, (ii) 966 shares purchased by VHCP Co-3 and (iii) 26,098 shares purchased by VHCP EG. F7 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.77 to $9.93, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: VHCP Management II, LLC ("VHCPM II") is the general partner of Venrock Healthcare Capital Partners II, L.P. ("VHCP II") and the manager of VHCP Co-Investment Holdings II, LLC ("VHCP Co-2"). VHCP Management III, LLC ("VHCPM III") is the general partner of VHCP III and the manager of VHCP Co-3. VHCP Management EG, LLC ("VHCPM EG") is the general partner of VHCP EG. Messrs. Shah and Koh are the voting members of VHCPM II, VHCPM III and VHCPM EG. Each of VHCPM II, VHCPM III, VHCPM EG, Shah and Koh expressly disclaims beneficial ownership over all shares held by VHCP II, VHCP Co-2, VHCP III, VHCP Co-3 and VHCP EG except to the extent of its or his indirect pecuniary interest therein. Read SEC document
July 13, 2022 Filed Jul 14, 2022 17:43 UTC	Tricida, Inc. TCDA · Entity 122050	PurchaseCommon Stock	32,856	$9.98	$327,902.88	Disclosure SEC source: 0001209191-22-042154 · doc4.xml · nonDerivative · entry 2 Venrock Healthcare Capital Partners II, L.P. · CIK 0001602264 · 10% owner VHCP Co-Investment Holdings II, LLC · CIK 0001615983 · 10% owner VHCP Management II, LLC · CIK 0001602263 · 10% owner Venrock Healthcare Capital Partners III, L.P. · CIK 0001738048 · 10% owner VHCP Co-Investment Holdings III, LLC · CIK 0001750761 · 10% owner VHCP Management III, LLC · CIK 0001738053 · 10% owner Venrock Healthcare Capital Partners EG, L.P. · CIK 0001808512 · 10% owner VHCP Management EG, LLC · CIK 0001808518 · 10% owner Koh Bong Y · CIK 0001615979 · 10% owner Shah Nimish P · CIK 0001698082 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Funds Disclosed balance after: 7,278,135 F4 · shares: Consists of (i) 8,638 shares purchased by VHCP III, (ii) 864 shares purchased by VHCP Co-3 and (iii) 23,354 shares purchased by VHCP EG. F5 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.97 to $10.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: VHCP Management II, LLC ("VHCPM II") is the general partner of Venrock Healthcare Capital Partners II, L.P. ("VHCP II") and the manager of VHCP Co-Investment Holdings II, LLC ("VHCP Co-2"). VHCP Management III, LLC ("VHCPM III") is the general partner of VHCP III and the manager of VHCP Co-3. VHCP Management EG, LLC ("VHCPM EG") is the general partner of VHCP EG. Messrs. Shah and Koh are the voting members of VHCPM II, VHCPM III and VHCPM EG. Each of VHCPM II, VHCPM III, VHCPM EG, Shah and Koh expressly disclaims beneficial ownership over all shares held by VHCP II, VHCP Co-2, VHCP III, VHCP Co-3 and VHCP EG except to the extent of its or his indirect pecuniary interest therein. Read SEC document
July 12, 2022 Filed Jul 14, 2022 17:43 UTC	Tricida, Inc. TCDA · Entity 122050	PurchaseCommon Stock	25,000	$9.81	$245,250.00	Disclosure SEC source: 0001209191-22-042154 · doc4.xml · nonDerivative · entry 1 Venrock Healthcare Capital Partners II, L.P. · CIK 0001602264 · 10% owner VHCP Co-Investment Holdings II, LLC · CIK 0001615983 · 10% owner VHCP Management II, LLC · CIK 0001602263 · 10% owner Venrock Healthcare Capital Partners III, L.P. · CIK 0001738048 · 10% owner VHCP Co-Investment Holdings III, LLC · CIK 0001750761 · 10% owner VHCP Management III, LLC · CIK 0001738053 · 10% owner Venrock Healthcare Capital Partners EG, L.P. · CIK 0001808512 · 10% owner VHCP Management EG, LLC · CIK 0001808518 · 10% owner Koh Bong Y · CIK 0001615979 · 10% owner Shah Nimish P · CIK 0001698082 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Funds Disclosed balance after: 7,245,279 F1 · shares: Consists of (i) 6,573 shares purchased by Venrock Healthcare Capital Partners III, L.P. ("VHCP III"), (ii) 657 shares purchased by VHCP Co- Investment Holdings III, LLC ("VHCP Co-3") and (iii) 17,770 shares purchased by Venrock Healthcare Capital Partners EG, L.P. ("VHCP EG"). F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.64 to $9.99, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: VHCP Management II, LLC ("VHCPM II") is the general partner of Venrock Healthcare Capital Partners II, L.P. ("VHCP II") and the manager of VHCP Co-Investment Holdings II, LLC ("VHCP Co-2"). VHCP Management III, LLC ("VHCPM III") is the general partner of VHCP III and the manager of VHCP Co-3. VHCP Management EG, LLC ("VHCPM EG") is the general partner of VHCP EG. Messrs. Shah and Koh are the voting members of VHCPM II, VHCPM III and VHCPM EG. Each of VHCPM II, VHCPM III, VHCPM EG, Shah and Koh expressly disclaims beneficial ownership over all shares held by VHCP II, VHCP Co-2, VHCP III, VHCP Co-3 and VHCP EG except to the extent of its or his indirect pecuniary interest therein. Read SEC document
July 12, 2022 Filed Jul 14, 2022 17:33 UTC	Vistagen Therapeutics, Inc. VTGN · Entity 7955	SaleCommon Stock	60,000	$0.89	$53,400.00	Disclosure SEC source: 0001209191-22-042152 · doc4.xml · nonDerivative · entry 1 Venrock Healthcare Capital Partners II, L.P. · CIK 0001602264 · 10% owner VHCP Co-Investment Holdings II, LLC · CIK 0001615983 · 10% owner VHCP Management II, LLC · CIK 0001602263 · 10% owner Venrock Healthcare Capital Partners III, L.P. · CIK 0001738048 · 10% owner VHCP Co-Investment Holdings III, LLC · CIK 0001750761 · 10% owner VHCP Management III, LLC · CIK 0001738053 · 10% owner Venrock Healthcare Capital Partners EG, L.P. · CIK 0001808512 · 10% owner VHCP Management EG, LLC · CIK 0001808518 · 10% owner Koh Bong Y · CIK 0001615979 · 10% owner Shah Nimish P · CIK 0001698082 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Funds Disclosed balance after: 20,637,286 F1 · shares: Consists of 14,348 shares sold by Venrock Healthcare Capital Partners II, L.P. ("VHCP II"), 5,814 shares sold by VHCP Co-Investment Holdings II, LLC ("VHCP II Co"), 4,688 shares sold by Venrock Healthcare Capital Partners III, L.P. ("VHCP III"), 469 shares sold by VHCP Co-Investment Holdings III, LLC ("VHCP III Co") and 34,681 shares sold by Venrock Healthcare Capital Partners EG, L.P. ("VHCP EG"). F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.86 to $0.91, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3 · balance_after: Consists of 4,935,020 shares held by VHCP II, 1,999,971 shares held by VHCP II Co, 1,612,582 shares held by VHCP III, 161,351 shares held by VHCP III Co and 11,928,362 shares held by VHCP EG. F4 · ownership.nature: VHCP Management II, LLC ("VHCPM II") is the sole general partner of VHCP II and the sole manager of VHCP II Co. VHCP Management III, LLC ("VHCPM III") is the sole general partner of VHCP III and the sole manager of VHCP III Co. VHCP Management EG, LLC ("VHCPM EG") is the sole general partner of VHCP EG. Dr. Bong Koh and Nimish Shah are the voting members of VHCPM II, VHCPM III and VHCPM EG. Dr. Koh, Mr. Shah, VHCPM II, VHCPM III and VHCPM EG disclaim beneficial ownership over all shares held by VHCP II, VHCP II Co, VHCP III, VHCP III Co and VHCP EG, except to the extent of their respective indirect pecuniary interests therein. Read SEC document
July 05, 2022 Filed Jul 6, 2022 16:55 UTC	Tricida, Inc. TCDA · Entity 122050	PurchaseCommon Stock	32,500	$9.53	$309,725.00	Disclosure SEC source: 0001209191-22-041196 · doc4.xml · nonDerivative · entry 2 Venrock Healthcare Capital Partners II, L.P. · CIK 0001602264 · 10% owner VHCP Co-Investment Holdings II, LLC · CIK 0001615983 · 10% owner VHCP Management II, LLC · CIK 0001602263 · 10% owner Venrock Healthcare Capital Partners III, L.P. · CIK 0001738048 · 10% owner VHCP Co-Investment Holdings III, LLC · CIK 0001750761 · 10% owner VHCP Management III, LLC · CIK 0001738053 · 10% owner Venrock Healthcare Capital Partners EG, L.P. · CIK 0001808512 · 10% owner VHCP Management EG, LLC · CIK 0001808518 · 10% owner Koh Bong Y · CIK 0001615979 · 10% owner Shah Nimish P · CIK 0001698082 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Funds Disclosed balance after: 7,220,279 F4 · shares: Consists of (i) 8,544 shares purchased by VHCP III, (ii) 855 shares purchased by VHCP Co-3 and (iii) 23,101 shares purchased by VHCP EG. F5 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.43 to $9.87, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: VHCP Management II, LLC ("VHCPM II") is the general partner of Venrock Healthcare Capital Partners II, L.P. ("VHCP II") and the manager of VHCP Co-Investment Holdings II, LLC ("VHCP Co-2"). VHCP Management III, LLC ("VHCPM III") is the general partner of VHCP III and the manager of VHCP Co-3. VHCP Management EG, LLC ("VHCPM EG") is the general partner of VHCP EG. Messrs. Shah and Koh are the voting members of VHCPM II, VHCPM III and VHCPM EG. Each of VHCPM II, VHCPM III, VHCPM EG, Shah and Koh expressly disclaims beneficial ownership over all shares held by VHCP II, VHCP Co-2, VHCP III, VHCP Co-3 and VHCP EG except to the extent of its or his indirect pecuniary interest therein. Read SEC document
July 01, 2022 Filed Jul 6, 2022 16:55 UTC	Tricida, Inc. TCDA · Entity 122050	PurchaseCommon Stock	55,700	$9.65	$537,505.00	Disclosure SEC source: 0001209191-22-041196 · doc4.xml · nonDerivative · entry 1 Venrock Healthcare Capital Partners II, L.P. · CIK 0001602264 · 10% owner VHCP Co-Investment Holdings II, LLC · CIK 0001615983 · 10% owner VHCP Management II, LLC · CIK 0001602263 · 10% owner Venrock Healthcare Capital Partners III, L.P. · CIK 0001738048 · 10% owner VHCP Co-Investment Holdings III, LLC · CIK 0001750761 · 10% owner VHCP Management III, LLC · CIK 0001738053 · 10% owner Venrock Healthcare Capital Partners EG, L.P. · CIK 0001808512 · 10% owner VHCP Management EG, LLC · CIK 0001808518 · 10% owner Koh Bong Y · CIK 0001615979 · 10% owner Shah Nimish P · CIK 0001698082 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Funds Disclosed balance after: 7,187,779 F1 · shares: Consists of (i) 14,644 shares purchased by Venrock Healthcare Capital Partners III, L.P. ("VHCP III"), (ii) 1,464 shares purchased by VHCP Co-Investment Holdings III, LLC ("VHCP Co-3") and (iii) 39,592 shares purchased by Venrock Healthcare Capital Partners EG, L.P. ("VHCP EG"). F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.48 to $10.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: VHCP Management II, LLC ("VHCPM II") is the general partner of Venrock Healthcare Capital Partners II, L.P. ("VHCP II") and the manager of VHCP Co-Investment Holdings II, LLC ("VHCP Co-2"). VHCP Management III, LLC ("VHCPM III") is the general partner of VHCP III and the manager of VHCP Co-3. VHCP Management EG, LLC ("VHCPM EG") is the general partner of VHCP EG. Messrs. Shah and Koh are the voting members of VHCPM II, VHCPM III and VHCPM EG. Each of VHCPM II, VHCPM III, VHCPM EG, Shah and Koh expressly disclaims beneficial ownership over all shares held by VHCP II, VHCP Co-2, VHCP III, VHCP Co-3 and VHCP EG except to the extent of its or his indirect pecuniary interest therein. Read SEC document
June 30, 2022 Filed Jun 30, 2022 16:57 UTC	Tricida, Inc. TCDA · Entity 122050	PurchaseCommon Stock	11,958	$9.66	$115,514.28	Disclosure SEC source: 0001209191-22-039936 · doc4.xml · nonDerivative · entry 3 Venrock Healthcare Capital Partners II, L.P. · CIK 0001602264 · 10% owner VHCP Co-Investment Holdings II, LLC · CIK 0001615983 · 10% owner VHCP Management II, LLC · CIK 0001602263 · 10% owner Venrock Healthcare Capital Partners III, L.P. · CIK 0001738048 · 10% owner VHCP Co-Investment Holdings III, LLC · CIK 0001750761 · 10% owner VHCP Management III, LLC · CIK 0001738053 · 10% owner Venrock Healthcare Capital Partners EG, L.P. · CIK 0001808512 · 10% owner VHCP Management EG, LLC · CIK 0001808518 · 10% owner Koh Bong Y · CIK 0001615979 · 10% owner Shah Nimish P · CIK 0001698082 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Funds Disclosed balance after: 7,132,079 F6 · shares: Consists of (i) 1,241 shares purchased by VHCP II, (ii) 502 shares purchased by VHCP Co-2, (iii) 2,685 shares purchased by VHCP III, (iv) 268 shares purchased by VHCP Co-3 and (v) 7,262 shares purchased by VHCP EG. F7 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.46 to $9.77, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: VHCP Management II, LLC ("VHCPM II") is the general partner of VHCP II and the manager of VHCP Co-2. VHCP Management III, LLC ("VHCPM III") is the general partner of VHCP III and the manager of VHCP Co-3. VHCP Management EG, LLC ("VHCPM EG") is the general partner of VHCP EG. Messrs. Shah and Koh are the voting members of VHCPM II, VHCPM III and VHCPM EG. Each of VHCPM II, VHCPM III, VHCPM EG, Shah and Koh expressly disclaims beneficial ownership over all shares held by VHCP II, VHCP Co-2, VHCP III, VHCP Co-3 and VHCP EG except to the extent of its or his indirect pecuniary interest therein. Read SEC document
June 29, 2022 Filed Jun 30, 2022 16:57 UTC	Tricida, Inc. TCDA · Entity 122050	PurchaseCommon Stock	16,546	$9.93	$164,301.78	Disclosure SEC source: 0001209191-22-039936 · doc4.xml · nonDerivative · entry 2 Venrock Healthcare Capital Partners II, L.P. · CIK 0001602264 · 10% owner VHCP Co-Investment Holdings II, LLC · CIK 0001615983 · 10% owner VHCP Management II, LLC · CIK 0001602263 · 10% owner Venrock Healthcare Capital Partners III, L.P. · CIK 0001738048 · 10% owner VHCP Co-Investment Holdings III, LLC · CIK 0001750761 · 10% owner VHCP Management III, LLC · CIK 0001738053 · 10% owner Venrock Healthcare Capital Partners EG, L.P. · CIK 0001808512 · 10% owner VHCP Management EG, LLC · CIK 0001808518 · 10% owner Koh Bong Y · CIK 0001615979 · 10% owner Shah Nimish P · CIK 0001698082 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Funds Disclosed balance after: 7,120,121 F4 · shares: Consists of (i) 1,717 shares purchased by VHCP II, (ii) 695 shares purchased by VHCP Co-2, (iii) 3,715 shares purchased by VHCP III, (iv) 371 shares purchased by VHCP Co-3 and (v) 10,048 shares purchased by VHCP EG. F5 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.87 to $10.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: VHCP Management II, LLC ("VHCPM II") is the general partner of VHCP II and the manager of VHCP Co-2. VHCP Management III, LLC ("VHCPM III") is the general partner of VHCP III and the manager of VHCP Co-3. VHCP Management EG, LLC ("VHCPM EG") is the general partner of VHCP EG. Messrs. Shah and Koh are the voting members of VHCPM II, VHCPM III and VHCPM EG. Each of VHCPM II, VHCPM III, VHCPM EG, Shah and Koh expressly disclaims beneficial ownership over all shares held by VHCP II, VHCP Co-2, VHCP III, VHCP Co-3 and VHCP EG except to the extent of its or his indirect pecuniary interest therein. Read SEC document
June 28, 2022 Filed Jun 30, 2022 16:57 UTC	Tricida, Inc. TCDA · Entity 122050	PurchaseCommon Stock	34,366	$9.71	$333,693.86	Disclosure SEC source: 0001209191-22-039936 · doc4.xml · nonDerivative · entry 1 Venrock Healthcare Capital Partners II, L.P. · CIK 0001602264 · 10% owner VHCP Co-Investment Holdings II, LLC · CIK 0001615983 · 10% owner VHCP Management II, LLC · CIK 0001602263 · 10% owner Venrock Healthcare Capital Partners III, L.P. · CIK 0001738048 · 10% owner VHCP Co-Investment Holdings III, LLC · CIK 0001750761 · 10% owner VHCP Management III, LLC · CIK 0001738053 · 10% owner Venrock Healthcare Capital Partners EG, L.P. · CIK 0001808512 · 10% owner VHCP Management EG, LLC · CIK 0001808518 · 10% owner Koh Bong Y · CIK 0001615979 · 10% owner Shah Nimish P · CIK 0001698082 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Funds Disclosed balance after: 7,103,575 F1 · shares: Consists of (i) 3,567 shares purchased by Venrock Healthcare Capital Partners II, L.P. ("VHCP II"), (ii) 1,442 shares purchased by VHCP Co- Investment Holdings II, LLC ("VHCP Co-2"), (iii) 7,715 shares purchased by Venrock Healthcare Capital Partners III, L.P. ("VHCP III"), (iv) 769 shares purchased by VHCP Co-Investment Holdings III, LLC ("VHCP Co-3") and (v) 20,873 shares purchased by Venrock Healthcare Capital Partners EG, L.P. ("VHCP EG"). F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.60 to $10.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: VHCP Management II, LLC ("VHCPM II") is the general partner of VHCP II and the manager of VHCP Co-2. VHCP Management III, LLC ("VHCPM III") is the general partner of VHCP III and the manager of VHCP Co-3. VHCP Management EG, LLC ("VHCPM EG") is the general partner of VHCP EG. Messrs. Shah and Koh are the voting members of VHCPM II, VHCPM III and VHCPM EG. Each of VHCPM II, VHCPM III, VHCPM EG, Shah and Koh expressly disclaims beneficial ownership over all shares held by VHCP II, VHCP Co-2, VHCP III, VHCP Co-3 and VHCP EG except to the extent of its or his indirect pecuniary interest therein. Read SEC document
June 24, 2022 Filed Jun 24, 2022 17:51 UTC	Tricida, Inc. TCDA · Entity 122050	PurchaseCommon Stock	149,120	$9.68	$1,443,481.60	Disclosure SEC source: 0001209191-22-039309 · doc4.xml · nonDerivative · entry 3 Venrock Healthcare Capital Partners II, L.P. · CIK 0001602264 · 10% owner VHCP Co-Investment Holdings II, LLC · CIK 0001615983 · 10% owner VHCP Management II, LLC · CIK 0001602263 · 10% owner Venrock Healthcare Capital Partners III, L.P. · CIK 0001738048 · 10% owner VHCP Co-Investment Holdings III, LLC · CIK 0001750761 · 10% owner VHCP Management III, LLC · CIK 0001738053 · 10% owner Venrock Healthcare Capital Partners EG, L.P. · CIK 0001808512 · 10% owner VHCP Management EG, LLC · CIK 0001808518 · 10% owner Koh Bong Y · CIK 0001615979 · 10% owner Shah Nimish P · CIK 0001698082 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Funds Disclosed balance after: 7,069,209 F4 · shares: Consists of (i) 15,479 shares purchased by VHCP II, (ii) 6,263 shares purchased by VHCP Co-2, (iii) 33,477 shares purchased by VHCP III, (iv) 3,340 shares purchased by VHCP Co-3 and (v) 90,561 shares purchased by VHCP EG. F5 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.56 to $10.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. F2 · ownership.nature: VHCP Management II, LLC ("VHCPM II") is the general partner of VHCP II and the manager of VHCP Co-2. VHCP Management III, LLC ("VHCPM III") is the general partner of VHCP III and the manager of VHCP Co-3. VHCP Management EG, LLC ("VHCPM EG") is the general partner of VHCP EG. Messrs. Shah and Koh are the voting members of VHCPM II, VHCPM III and VHCPM EG. Each of VHCPM II, VHCPM III, VHCPM EG, Shah and Koh expressly disclaims beneficial ownership over all shares held by VHCP II, VHCP Co-2, VHCP III, VHCP Co-3 and VHCP EG except to the extent of its or his indirect pecuniary interest therein. Read SEC document
June 23, 2022 Filed Jun 24, 2022 17:51 UTC	Tricida, Inc. TCDA · Entity 122050	PurchaseCommon Stock	200,000	$10.50	$2,100,000.00	Disclosure SEC source: 0001209191-22-039309 · doc4.xml · nonDerivative · entry 2 Venrock Healthcare Capital Partners II, L.P. · CIK 0001602264 · 10% owner VHCP Co-Investment Holdings II, LLC · CIK 0001615983 · 10% owner VHCP Management II, LLC · CIK 0001602263 · 10% owner Venrock Healthcare Capital Partners III, L.P. · CIK 0001738048 · 10% owner VHCP Co-Investment Holdings III, LLC · CIK 0001750761 · 10% owner VHCP Management III, LLC · CIK 0001738053 · 10% owner Venrock Healthcare Capital Partners EG, L.P. · CIK 0001808512 · 10% owner VHCP Management EG, LLC · CIK 0001808518 · 10% owner Koh Bong Y · CIK 0001615979 · 10% owner Shah Nimish P · CIK 0001698082 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Funds Disclosed balance after: 6,920,089 F3 · shares: Consists of (i) 20,760 shares purchased by VHCP II, (ii) 8,400 shares purchased by VHCP Co-2, (iii) 44,900 shares purchased by VHCP III, (iv) 4,480 shares purchased by VHCP Co-3 and (v) 121,460 shares purchased by VHCP EG. F2 · ownership.nature: VHCP Management II, LLC ("VHCPM II") is the general partner of VHCP II and the manager of VHCP Co-2. VHCP Management III, LLC ("VHCPM III") is the general partner of VHCP III and the manager of VHCP Co-3. VHCP Management EG, LLC ("VHCPM EG") is the general partner of VHCP EG. Messrs. Shah and Koh are the voting members of VHCPM II, VHCPM III and VHCPM EG. Each of VHCPM II, VHCPM III, VHCPM EG, Shah and Koh expressly disclaims beneficial ownership over all shares held by VHCP II, VHCP Co-2, VHCP III, VHCP Co-3 and VHCP EG except to the extent of its or his indirect pecuniary interest therein. Read SEC document
June 22, 2022 Filed Jun 24, 2022 17:51 UTC	Tricida, Inc. TCDA · Entity 122050	PurchaseCommon Stock	142,900	$10.90	$1,557,610.00	Disclosure SEC source: 0001209191-22-039309 · doc4.xml · nonDerivative · entry 1 Venrock Healthcare Capital Partners II, L.P. · CIK 0001602264 · 10% owner VHCP Co-Investment Holdings II, LLC · CIK 0001615983 · 10% owner VHCP Management II, LLC · CIK 0001602263 · 10% owner Venrock Healthcare Capital Partners III, L.P. · CIK 0001738048 · 10% owner VHCP Co-Investment Holdings III, LLC · CIK 0001750761 · 10% owner VHCP Management III, LLC · CIK 0001738053 · 10% owner Venrock Healthcare Capital Partners EG, L.P. · CIK 0001808512 · 10% owner VHCP Management EG, LLC · CIK 0001808518 · 10% owner Koh Bong Y · CIK 0001615979 · 10% owner Shah Nimish P · CIK 0001698082 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Funds Disclosed balance after: 6,720,089 F1 · shares: Consists of (i) 14,833 shares purchased by Venrock Healthcare Capital Partners II, L.P. ("VHCP II"), (ii) 6,002 shares purchased by VHCP Co- Investment Holdings II, LLC ("VHCP Co-2"), (iii) 32,081 shares purchased by Venrock Healthcare Capital Partners III, L.P. ("VHCP III"), (iv) 3,201 shares purchased by VHCP Co-Investment Holdings III, LLC ("VHCP Co-3") and (v) 86,783 shares purchased by Venrock Healthcare Capital Partners EG, L.P. ("VHCP EG"). F2 · ownership.nature: VHCP Management II, LLC ("VHCPM II") is the general partner of VHCP II and the manager of VHCP Co-2. VHCP Management III, LLC ("VHCPM III") is the general partner of VHCP III and the manager of VHCP Co-3. VHCP Management EG, LLC ("VHCPM EG") is the general partner of VHCP EG. Messrs. Shah and Koh are the voting members of VHCPM II, VHCPM III and VHCPM EG. Each of VHCPM II, VHCPM III, VHCPM EG, Shah and Koh expressly disclaims beneficial ownership over all shares held by VHCP II, VHCP Co-2, VHCP III, VHCP Co-3 and VHCP EG except to the extent of its or his indirect pecuniary interest therein. Read SEC document
June 16, 2022 Filed Jun 21, 2022 17:12 UTC	Tricida, Inc. TCDA · Entity 122050	PurchaseCommon Stock	5,951	$9.69	$57,665.19	Disclosure SEC source: 0001209191-22-038479 · doc4.xml · nonDerivative · entry 1 Venrock Healthcare Capital Partners II, L.P. · CIK 0001602264 · 10% owner VHCP Co-Investment Holdings II, LLC · CIK 0001615983 · 10% owner VHCP Management II, LLC · CIK 0001602263 · 10% owner Venrock Healthcare Capital Partners III, L.P. · CIK 0001738048 · 10% owner VHCP Co-Investment Holdings III, LLC · CIK 0001750761 · 10% owner VHCP Management III, LLC · CIK 0001738053 · 10% owner Venrock Healthcare Capital Partners EG, L.P. · CIK 0001808512 · 10% owner VHCP Management EG, LLC · CIK 0001808518 · 10% owner Koh Bong Y · CIK 0001615979 · 10% owner Shah Nimish P · CIK 0001698082 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By funds Disclosed balance after: 6,577,189 F1 · shares: Consists of (i) 1,565 shares purchased by Venrock Healthcare Capital Partners III, L.P. ("VHCP III"), (ii) 156 shares purchased by VHCP Co- Investment Holdings III, LLC ("VHCP Co-3") and (iii) 4,230 shares purchased by Venrock Healthcare Capital Partners EG, L.P. ("VHCP EG"). F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.66 to $9.75, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: VHCP Management II, LLC ("VHCPM II") is the general partner of Venrock Healthcare Capital Partners II, L.P. ("VHCP II") and the manager of VHCP Co-Investment Holdings II, LLC ("VHCP Co-2"). VHCP Management III, LLC ("VHCPM III") is the general partner of VHCP III and the manager of VHCP Co-3. VHCP Management EG, LLC ("VHCPM EG") is the general partner of VHCP EG. Messrs. Shah and Koh are the voting members of VHCPM II, VHCPM III and VHCPM EG. Each of VHCPM II, VHCPM III, VHCPM EG, Shah and Koh expressly disclaims beneficial ownership over all shares held by VHCP II, VHCP Co-2, VHCP III, VHCP Co-3 and VHCP EG except to the extent of its or his indirect pecuniary interest therein. Read SEC document
June 14, 2022 Filed Jun 14, 2022 17:00 UTC	Tricida, Inc. TCDA · Entity 122050	PurchaseCommon Stock	10,000	$8.72	$87,200.00	Disclosure SEC source: 0001209191-22-036738 · doc4.xml · nonDerivative · entry 3 Venrock Healthcare Capital Partners II, L.P. · CIK 0001602264 · 10% owner VHCP Co-Investment Holdings II, LLC · CIK 0001615983 · 10% owner VHCP Management II, LLC · CIK 0001602263 · 10% owner Venrock Healthcare Capital Partners III, L.P. · CIK 0001738048 · 10% owner VHCP Co-Investment Holdings III, LLC · CIK 0001750761 · 10% owner VHCP Management III, LLC · CIK 0001738053 · 10% owner Venrock Healthcare Capital Partners EG, L.P. · CIK 0001808512 · 10% owner VHCP Management EG, LLC · CIK 0001808518 · 10% owner Koh Bong Y · CIK 0001615979 · 10% owner Shah Nimish P · CIK 0001698082 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Funds Disclosed balance after: 6,571,238 F6 · shares: Consists of (i) 2,629 shares purchased by VHCP III, (ii) 263 shares purchased by VHCP Co-3 and (iii) 7,108 shares purchased by VHCP EG. F7 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.60 to $8.89, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: VHCP Management II, LLC ("VHCPM II") is the general partner of VHCP II and the manager of VHCP Co-2. VHCP Management III, LLC ("VHCPM III") is the general partner of VHCP III and the manager of VHCP Co-3. VHCP Management EG, LLC ("VHCPM EG") is the general partner of VHCP EG. Messrs. Shah and Koh are the voting members of VHCPM II, VHCPM III and VHCPM EG. Each of VHCPM II, VHCPM III, VHCPM EG, Shah and Koh expressly disclaims beneficial ownership over all shares held by VHCP II, VHCP Co-2, VHCP III, VHCP Co-3 and VHCP EG except to the extent of its or his indirect pecuniary interest therein. Read SEC document
June 13, 2022 Filed Jun 14, 2022 17:00 UTC	Tricida, Inc. TCDA · Entity 122050	PurchaseCommon Stock	50,000	$8.14	$407,000.00	Disclosure SEC source: 0001209191-22-036738 · doc4.xml · nonDerivative · entry 2 Venrock Healthcare Capital Partners II, L.P. · CIK 0001602264 · 10% owner VHCP Co-Investment Holdings II, LLC · CIK 0001615983 · 10% owner VHCP Management II, LLC · CIK 0001602263 · 10% owner Venrock Healthcare Capital Partners III, L.P. · CIK 0001738048 · 10% owner VHCP Co-Investment Holdings III, LLC · CIK 0001750761 · 10% owner VHCP Management III, LLC · CIK 0001738053 · 10% owner Venrock Healthcare Capital Partners EG, L.P. · CIK 0001808512 · 10% owner VHCP Management EG, LLC · CIK 0001808518 · 10% owner Koh Bong Y · CIK 0001615979 · 10% owner Shah Nimish P · CIK 0001698082 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Funds Disclosed balance after: 6,561,238 F4 · shares: Consists of (i) 1,762 shares purchased by Venrock Healthcare Capital Partners II, L.P. ("VHCP II"), (ii) 713 shares purchased by VHCP Co-Investment Holdings II, LLC ("VHCP Co-2"), (iii) 12,494 shares purchased by VHCP III, (iv) 1,249 shares purchased by VHCP Co-3 and (v) 33,782 shares purchased by VHCP EG. F5 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.02 to $8.28, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: VHCP Management II, LLC ("VHCPM II") is the general partner of VHCP II and the manager of VHCP Co-2. VHCP Management III, LLC ("VHCPM III") is the general partner of VHCP III and the manager of VHCP Co-3. VHCP Management EG, LLC ("VHCPM EG") is the general partner of VHCP EG. Messrs. Shah and Koh are the voting members of VHCPM II, VHCPM III and VHCPM EG. Each of VHCPM II, VHCPM III, VHCPM EG, Shah and Koh expressly disclaims beneficial ownership over all shares held by VHCP II, VHCP Co-2, VHCP III, VHCP Co-3 and VHCP EG except to the extent of its or his indirect pecuniary interest therein. Read SEC document
June 10, 2022 Filed Jun 14, 2022 17:00 UTC	Tricida, Inc. TCDA · Entity 122050	PurchaseCommon Stock	58,054	$8.91	$517,261.14	Disclosure SEC source: 0001209191-22-036738 · doc4.xml · nonDerivative · entry 1 Venrock Healthcare Capital Partners II, L.P. · CIK 0001602264 · 10% owner VHCP Co-Investment Holdings II, LLC · CIK 0001615983 · 10% owner VHCP Management II, LLC · CIK 0001602263 · 10% owner Venrock Healthcare Capital Partners III, L.P. · CIK 0001738048 · 10% owner VHCP Co-Investment Holdings III, LLC · CIK 0001750761 · 10% owner VHCP Management III, LLC · CIK 0001738053 · 10% owner Venrock Healthcare Capital Partners EG, L.P. · CIK 0001808512 · 10% owner VHCP Management EG, LLC · CIK 0001808518 · 10% owner Koh Bong Y · CIK 0001615979 · 10% owner Shah Nimish P · CIK 0001698082 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Funds Disclosed balance after: 6,511,238 F1 · shares: Consists of (i) 15,262 shares purchased by Venrock Healthcare Capital Partners III, L.P. ("VHCP III"), (ii) 1,527 shares purchased by VHCP Co-Investment Holdings III, LLC ("VHCP Co-3") and (iii) 41,265 shares purchased by Venrock Healthcare Capital Partners EG, L.P. ("VHCP EG"). F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.76 to $9.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: VHCP Management II, LLC ("VHCPM II") is the general partner of VHCP II and the manager of VHCP Co-2. VHCP Management III, LLC ("VHCPM III") is the general partner of VHCP III and the manager of VHCP Co-3. VHCP Management EG, LLC ("VHCPM EG") is the general partner of VHCP EG. Messrs. Shah and Koh are the voting members of VHCPM II, VHCPM III and VHCPM EG. Each of VHCPM II, VHCPM III, VHCPM EG, Shah and Koh expressly disclaims beneficial ownership over all shares held by VHCP II, VHCP Co-2, VHCP III, VHCP Co-3 and VHCP EG except to the extent of its or his indirect pecuniary interest therein. Read SEC document
June 09, 2022 Filed Jun 9, 2022 18:33 UTC	Tricida, Inc. TCDA · Entity 122050	PurchaseCommon Stock	109,100	$8.97	$978,627.00	Disclosure SEC source: 0001209191-22-035591 · doc4.xml · nonDerivative · entry 3 Venrock Healthcare Capital Partners II, L.P. · CIK 0001602264 · 10% owner VHCP Co-Investment Holdings II, LLC · CIK 0001615983 · 10% owner VHCP Management II, LLC · CIK 0001602263 · 10% owner Venrock Healthcare Capital Partners III, L.P. · CIK 0001738048 · 10% owner VHCP Co-Investment Holdings III, LLC · CIK 0001750761 · 10% owner VHCP Management III, LLC · CIK 0001738053 · 10% owner Venrock Healthcare Capital Partners EG, L.P. · CIK 0001808512 · 10% owner VHCP Management EG, LLC · CIK 0001808518 · 10% owner Koh Bong Y · CIK 0001615979 · 10% owner Shah Nimish P · CIK 0001698082 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Funds Disclosed balance after: 6,453,184 F6 · shares: Consists of (i) 2,697 shares purchased by VHCP II, (ii) 1,093 shares purchased by VHCP Co-2, (iii) 27,686 shares purchased by VHCP III, (iv) 2,768 shares purchased by VHCP Co-3 and (v) 74,856 shares purchased by VHCP EG. F7 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.74 to $9.50, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: VHCP Management II, LLC ("VHCPM II") is the general partner of VHCP II and the manager of VHCP Co-2. VHCP Management III, LLC ("VHCPM III") is the general partner of VHCP III and the manager of VHCP Co-3. VHCP Management EG, LLC ("VHCPM EG") is the general partner of VHCP EG. Messrs. Shah and Koh are the voting members of VHCPM II, VHCPM III and VHCPM EG. Each of VHCPM II, VHCPM III, VHCPM EG, Shah and Koh expressly disclaims beneficial ownership over all shares held by VHCP II, VHCP Co-2, VHCP III, VHCP Co-3 and VHCP EG except to the extent of its or his indirect pecuniary interest therein. Read SEC document
June 08, 2022 Filed Jun 9, 2022 18:33 UTC	Tricida, Inc. TCDA · Entity 122050	PurchaseCommon Stock	111,111	$9.51	$1,056,665.61	Disclosure SEC source: 0001209191-22-035591 · doc4.xml · nonDerivative · entry 2 Venrock Healthcare Capital Partners II, L.P. · CIK 0001602264 · 10% owner VHCP Co-Investment Holdings II, LLC · CIK 0001615983 · 10% owner VHCP Management II, LLC · CIK 0001602263 · 10% owner Venrock Healthcare Capital Partners III, L.P. · CIK 0001738048 · 10% owner VHCP Co-Investment Holdings III, LLC · CIK 0001750761 · 10% owner VHCP Management III, LLC · CIK 0001738053 · 10% owner Venrock Healthcare Capital Partners EG, L.P. · CIK 0001808512 · 10% owner VHCP Management EG, LLC · CIK 0001808518 · 10% owner Koh Bong Y · CIK 0001615979 · 10% owner Shah Nimish P · CIK 0001698082 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Funds Disclosed balance after: 6,344,084 F4 · shares: Consists of (i) 29,211 shares purchased by VHCP III, (ii) 2,922 shares purchased by VHCP Co-3 and (iii) 78,978 shares purchased by VHCP EG. F5 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.31 to $9.74, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: VHCP Management II, LLC ("VHCPM II") is the general partner of VHCP II and the manager of VHCP Co-2. VHCP Management III, LLC ("VHCPM III") is the general partner of VHCP III and the manager of VHCP Co-3. VHCP Management EG, LLC ("VHCPM EG") is the general partner of VHCP EG. Messrs. Shah and Koh are the voting members of VHCPM II, VHCPM III and VHCPM EG. Each of VHCPM II, VHCPM III, VHCPM EG, Shah and Koh expressly disclaims beneficial ownership over all shares held by VHCP II, VHCP Co-2, VHCP III, VHCP Co-3 and VHCP EG except to the extent of its or his indirect pecuniary interest therein. Read SEC document
June 07, 2022 Filed Jun 9, 2022 18:33 UTC	Tricida, Inc. TCDA · Entity 122050	PurchaseCommon Stock	367,813	$9.89	$3,637,670.57	Disclosure SEC source: 0001209191-22-035591 · doc4.xml · nonDerivative · entry 1 Venrock Healthcare Capital Partners II, L.P. · CIK 0001602264 · 10% owner VHCP Co-Investment Holdings II, LLC · CIK 0001615983 · 10% owner VHCP Management II, LLC · CIK 0001602263 · 10% owner Venrock Healthcare Capital Partners III, L.P. · CIK 0001738048 · 10% owner VHCP Co-Investment Holdings III, LLC · CIK 0001750761 · 10% owner VHCP Management III, LLC · CIK 0001738053 · 10% owner Venrock Healthcare Capital Partners EG, L.P. · CIK 0001808512 · 10% owner VHCP Management EG, LLC · CIK 0001808518 · 10% owner Koh Bong Y · CIK 0001615979 · 10% owner Shah Nimish P · CIK 0001698082 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Funds Disclosed balance after: 6,232,973 F1 · shares: Consists of (i) 38,179 shares purchased by Venrock Healthcare Capital Partners II, L.P. ("VHCP II"), (ii) 15,446 shares purchased by VHCP Co-Investment Holdings II, LLC ("VHCP Co-2"), (iii) 82,575 shares purchased by Venrock Healthcare Capital Partners III, L.P. ("VHCP III"), (iv) 8,239 shares purchased by VHCP Co-Investment Holdings III, LLC ("VHCP Co-3") and (v) 223,374 shares purchased by Venrock Healthcare Capital Partners EG, L.P. ("VHCP EG"). F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.74 to $10.05, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: VHCP Management II, LLC ("VHCPM II") is the general partner of VHCP II and the manager of VHCP Co-2. VHCP Management III, LLC ("VHCPM III") is the general partner of VHCP III and the manager of VHCP Co-3. VHCP Management EG, LLC ("VHCPM EG") is the general partner of VHCP EG. Messrs. Shah and Koh are the voting members of VHCPM II, VHCPM III and VHCPM EG. Each of VHCPM II, VHCPM III, VHCPM EG, Shah and Koh expressly disclaims beneficial ownership over all shares held by VHCP II, VHCP Co-2, VHCP III, VHCP Co-3 and VHCP EG except to the extent of its or his indirect pecuniary interest therein. Read SEC document
June 06, 2022 Filed Jun 6, 2022 17:19 UTC	Tricida, Inc. TCDA · Entity 122050	PurchaseCommon Stock	91,506	$9.35	$855,581.10	Disclosure SEC source: 0001209191-22-034586 · doc4.xml · nonDerivative · entry 3 Venrock Healthcare Capital Partners II, L.P. · CIK 0001602264 · 10% owner VHCP Co-Investment Holdings II, LLC · CIK 0001615983 · 10% owner VHCP Management II, LLC · CIK 0001602263 · 10% owner Venrock Healthcare Capital Partners III, L.P. · CIK 0001738048 · 10% owner VHCP Co-Investment Holdings III, LLC · CIK 0001750761 · 10% owner VHCP Management III, LLC · CIK 0001738053 · 10% owner Venrock Healthcare Capital Partners EG, L.P. · CIK 0001808512 · 10% owner VHCP Management EG, LLC · CIK 0001808518 · 10% owner Koh Bong Y · CIK 0001615979 · 10% owner Shah Nimish P · CIK 0001698082 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Funds Disclosed balance after: 5,865,160 F6 · shares: Consists of (i) 9,498 shares purchased by VHCP II, (ii) 3,843 shares purchased by VHCP Co-2, (iii) 20,543 shares purchased by VHCP III, (iv) 2,050 shares purchased by VHCP Co-3 and (v) 55,572 shares purchased by VHCP EG. F7 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.16 to $9.50, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: VHCP Management II, LLC ("VHCPM II") is the general partner of VHCP II and the manager of VHCP Co-2. VHCP Management III, LLC ("VHCPM III") is the general partner of VHCP III and the manager of VHCP Co-3. VHCP Management EG, LLC ("VHCPM EG") is the general partner of VHCP EG. Messrs. Shah and Koh are the voting members of VHCPM II, VHCPM III and VHCPM EG. Each of VHCPM II, VHCPM III, VHCPM EG, Shah and Koh expressly disclaims beneficial ownership over all shares held by VHCP II, VHCP Co-2, VHCP III, VHCP Co-3 and VHCP EG except to the extent of its or his indirect pecuniary interest therein. Read SEC document
June 03, 2022 Filed Jun 6, 2022 17:19 UTC	Tricida, Inc. TCDA · Entity 122050	PurchaseCommon Stock	37,643	$9.33	$351,209.19	Disclosure SEC source: 0001209191-22-034586 · doc4.xml · nonDerivative · entry 2 Venrock Healthcare Capital Partners II, L.P. · CIK 0001602264 · 10% owner VHCP Co-Investment Holdings II, LLC · CIK 0001615983 · 10% owner VHCP Management II, LLC · CIK 0001602263 · 10% owner Venrock Healthcare Capital Partners III, L.P. · CIK 0001738048 · 10% owner VHCP Co-Investment Holdings III, LLC · CIK 0001750761 · 10% owner VHCP Management III, LLC · CIK 0001738053 · 10% owner Venrock Healthcare Capital Partners EG, L.P. · CIK 0001808512 · 10% owner VHCP Management EG, LLC · CIK 0001808518 · 10% owner Koh Bong Y · CIK 0001615979 · 10% owner Shah Nimish P · CIK 0001698082 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Funds Disclosed balance after: 5,773,654 F4 · shares: Consists of (i) 3,907 shares purchased by VHCP II, (ii) 1,581 shares purchased by VHCP Co-2, (iii) 8,451 shares purchased by VHCP III, (iv) 843 shares purchased by VHCP Co-3 and (v) 22,861 shares purchased by VHCP EG. F5 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.11 to $9.50, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: VHCP Management II, LLC ("VHCPM II") is the general partner of VHCP II and the manager of VHCP Co-2. VHCP Management III, LLC ("VHCPM III") is the general partner of VHCP III and the manager of VHCP Co-3. VHCP Management EG, LLC ("VHCPM EG") is the general partner of VHCP EG. Messrs. Shah and Koh are the voting members of VHCPM II, VHCPM III and VHCPM EG. Each of VHCPM II, VHCPM III, VHCPM EG, Shah and Koh expressly disclaims beneficial ownership over all shares held by VHCP II, VHCP Co-2, VHCP III, VHCP Co-3 and VHCP EG except to the extent of its or his indirect pecuniary interest therein. Read SEC document
June 02, 2022 Filed Jun 6, 2022 17:19 UTC	Tricida, Inc. TCDA · Entity 122050	PurchaseCommon Stock	61,722	$8.78	$541,919.16	Disclosure SEC source: 0001209191-22-034586 · doc4.xml · nonDerivative · entry 1 Venrock Healthcare Capital Partners II, L.P. · CIK 0001602264 · 10% owner VHCP Co-Investment Holdings II, LLC · CIK 0001615983 · 10% owner VHCP Management II, LLC · CIK 0001602263 · 10% owner Venrock Healthcare Capital Partners III, L.P. · CIK 0001738048 · 10% owner VHCP Co-Investment Holdings III, LLC · CIK 0001750761 · 10% owner VHCP Management III, LLC · CIK 0001738053 · 10% owner Venrock Healthcare Capital Partners EG, L.P. · CIK 0001808512 · 10% owner VHCP Management EG, LLC · CIK 0001808518 · 10% owner Koh Bong Y · CIK 0001615979 · 10% owner Shah Nimish P · CIK 0001698082 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Funds Disclosed balance after: 5,736,011 F1 · shares: Consists of (i) 6,407 shares purchased by Venrock Healthcare Capital Partners II, L.P. ("VHCP II"), (ii) 2,592 shares purchased by VHCP Co-Investment Holdings II, LLC ("VHCP Co-2"), (iii) 13,857 shares purchased by Venrock Healthcare Capital Partners III, L.P. ("VHCP III"), (iv), 1,383 shares purchased by VHCP Co-Investment Holdings III, LLC ("VHCP Co-3") and (v) 37,483 shares purchased by Venrock Healthcare Capital Partners EG, L.P. ("VHCP EG"). F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.73 to $8.83, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: VHCP Management II, LLC ("VHCPM II") is the general partner of VHCP II and the manager of VHCP Co-2. VHCP Management III, LLC ("VHCPM III") is the general partner of VHCP III and the manager of VHCP Co-3. VHCP Management EG, LLC ("VHCPM EG") is the general partner of VHCP EG. Messrs. Shah and Koh are the voting members of VHCPM II, VHCPM III and VHCPM EG. Each of VHCPM II, VHCPM III, VHCPM EG, Shah and Koh expressly disclaims beneficial ownership over all shares held by VHCP II, VHCP Co-2, VHCP III, VHCP Co-3 and VHCP EG except to the extent of its or his indirect pecuniary interest therein. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.